<SEC-DOCUMENT>0001214659-20-010243.txt : 20201208
<SEC-HEADER>0001214659-20-010243.hdr.sgml : 20201208
<ACCEPTANCE-DATETIME>20201207185616
ACCESSION NUMBER:		0001214659-20-010243
CONFORMED SUBMISSION TYPE:	424B1
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20201208
DATE AS OF CHANGE:		20201207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DPW Holdings, Inc.
		CENTRAL INDEX KEY:			0000896493
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				941721931
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-250980
		FILM NUMBER:		201373896

	BUSINESS ADDRESS:	
		STREET 1:		201 SHIPYARD WAY
		STREET 2:		SUITE E
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
		BUSINESS PHONE:		(949) 444-5464

	MAIL ADDRESS:	
		STREET 1:		201 SHIPYARD WAY
		STREET 2:		SUITE E
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIGITAL POWER CORP
		DATE OF NAME CHANGE:	19960823
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B1
<SEQUENCE>1
<FILENAME>r127200424b1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></P>



<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(1)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="text-align: right; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>Registration No. 333-250980</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B></B></P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<IMG SRC="dpwlogo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DPW HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 5,061,289&nbsp;Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consisting of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 155,660 Shares of Common Stock
Issuable upon Conversion of a Note</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 4,905,629 Shares of Common Stock
Issuable upon Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;This prospectus relates to the resale
or other disposition from time to time of up to 5,061,289<B>&nbsp;</B>shares of our common stock to be offered by the persons and
entities listed as selling stockholders in this prospectus, consisting of: (i) 155,660 shares of common stock issuable upon the
conversion of a convertible note (the &ldquo;Conversion Shares&rdquo;) and (ii) 4,905,629 shares of common stock (the &ldquo;Warrant
Shares&rdquo;) issuable upon the exercise of warrants, as described in the following transactions.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February
10, 2020, we entered into a Master Exchange Agreement (the &ldquo;Exchange Agreement&rdquo;) with Esousa Holdings, LLC (&ldquo;Esousa&rdquo;)
pursuant to which, among other items, it acquired approximately $4.2 million in certain promissory notes, including accrued but
unpaid interest, that had been previously issued by us to other entities. Pursuant to the Exchange Agreement, we issued Esousa
a warrant to purchase 1,832,597 shares of common stock (the &ldquo;MEA Warrant&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning
on February 27, 2020 and ending on July 24, 2020, we <FONT STYLE="background-color: white">issued certain promissory notes (the
&ldquo;Esousa Term Notes&rdquo;) to Esousa. In connection with the issuance of the Esousa Term Notes, we agreed to issue to Esousa,
upon approval of the NYSE American, LLC (the &ldquo;NYSE American&rdquo;), warrants to purchase an aggregate of 1,536,655 shares
of common stock (the &ldquo;Esousa Term Warrants&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
April 14, 2020, we issued to Jess Mogul (i) a convertible promissory note in the principal amount of $100,000 and (ii) a warrant
to <FONT STYLE="background-color: white">purchase up to 45,242 shares of common stock (the &ldquo;Mogul Warrant&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May 28,
2020, we entered into a securities purchase and exchange agreement with Cavalry Fund I LP providing for the (i) the exchange of
an outstanding secured promissory note, (ii) the issuance of a promissory note, and (iii) a warrant to <FONT STYLE="background-color: white">purchase
400,000 shares of common stock (the &ldquo;Cavalry Warrant&rdquo;)</FONT>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="background-color: white">On
June 26, 2020, we issued to several institutional investors promissory notes (the &ldquo;EMF Notes&rdquo;) in the aggregate principal
face amount of $800,000. In connection therewith, we delivered to the investors warrants (the &ldquo;EMF Warrants&rdquo;) to purchase
an aggregate of up to 361,991 shares of common stock at an exercise price of $2.43.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On August 21, 2020, we issued to JLA Realty Associates, LLC
a convertible promissory note in the principal amount of $330,000 (the &ldquo;JLA Note&rdquo;) convertible into the Conversion
Shares.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may, from time to time, sell, transfer
or otherwise dispose of any or all of their shares of our common stock on any stock exchange, market or trading facility on which
the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the
time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated
prices. See &ldquo;Plan of Distribution&rdquo; on page 34.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not offering
any shares of our common stock for sale under this prospectus. We will not receive any of the proceeds from the sale of common
stock by the selling&nbsp;stockholders, though we will receive proceeds in the event of any warrant exercise for cash. We will
pay all the expenses, estimated to be approximately $17,115, in connection with this offering, other than underwriting commissions
and discounts and counsel fees and expenses of the selling stockholders. The shares of our common stock are being registered to
satisfy contractual obligations owed by us to the selling stockholders pursuant to their respective transaction documents.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
traded on NYSE American under the symbol &ldquo;DPW.&rdquo; The last reported sale price for the common stock on the NYSE American
on November 23, 2020 was&nbsp;$7.19&nbsp;per share.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may amend or supplement
this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any
amendments or supplements carefully before you make your investment decision.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>An investment
in our common stock involves a high degree of risk. You should review carefully the risks and uncertainties described under
the heading &ldquo;Risk Factors&rdquo; contained herein on page 8 and in our Annual Report on Form 10-K/A for the year ended
December 31, 2019, as well as our subsequently filed periodic and current reports, which we file with the Securities and
Exchange Commission and which are incorporated by reference into the registration statement of which this prospectus is a
part. You should read the entire prospectus carefully before you make your investment decision.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is December 8, 2020.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="white-space: nowrap; width: 93%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 6%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>
        <P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">About this Prospectus</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Disclosure Regarding Forward-Looking Statements</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">About the Company</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Risk Factors</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Use of Proceeds</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Selling Stockholders</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Plan of Distribution</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Description of Our Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Legal Matters</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Experts</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Where you can find more Information</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Incorporation of Documents by Reference</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">40</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is
part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;
or the &ldquo;<B>Commission</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this
prospectus and the information and documents incorporated by reference carefully. Such documents contain important information
you should consider when making your investment decision. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Documents
Incorporated by Reference&rdquo; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus may
be supplemented from time to time to add, to update or change information in this prospectus. Any statement contained in this prospectus
will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such prospectus
supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus
only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. You should rely
only on the information contained or incorporated by reference in this prospectus, any applicable prospectus supplement or any
related free writing prospectus. We have not authorized any other person to provide you with different information. If anyone provides
you with different or inconsistent information, you should not rely on it. No dealer, salesperson or other person is authorized
to give any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any
related free writing prospectus. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities,
in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus
or any prospectus supplement, as well as information we have filed with the SEC that is incorporated by reference, is accurate
as of the date on the front of those documents only, regardless of the time of delivery of this prospectus or any applicable prospectus
supplement, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed
since those dates.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No person is authorized
in connection with this prospectus to give any information or to make any representations about us, the securities offered hereby
or any matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any
other information or representation is given or made, such information or representation may not be relied upon as having been
authorized by us.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus contains
summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents
for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents
referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement
of which this prospectus is a part, and you may obtain copies of those documents as described below under &ldquo;Where You Can
Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For investors outside
the United States: Neither we nor any Underwriter has done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required
to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise stated
or the context requires otherwise, references to &ldquo;DPW,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo;
or &ldquo;our&rdquo; are to DPW Holdings, Inc.&nbsp;and its subsidiaries.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 6; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DISCLOSURE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and
the documents incorporated by reference in it contain forward-looking statements regarding future events and our future results
that are subject to the safe harbors created under the Securities Act of 1933 and the Securities Exchange Act of 1934. All statements
other than statements of historical facts are statements that could be deemed forward-looking statements. These statements are
based on our expectations, beliefs, forecasts, intentions and future strategies and are signified by the words &ldquo;expects,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;intends,&rdquo; &ldquo;believes&rdquo; or similar language. In addition, any statements that
refer to projections of our future financial performance, our anticipated growth, trends in our business and other characterizations
of future events or circumstances are forward-looking statements. These forward-looking statements are only predictions and are
subject to risks, uncertainties and assumptions that are difficult to predict, including those identified above, under &ldquo;Risk
Factors&rdquo; and elsewhere in this prospectus. Therefore, actual results may differ materially and adversely from those expressed
in any forward-looking statements. All forward-looking statements included in this prospectus are based on information available
to us on the date of this prospectus and speak only as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We disclaim any current
intention to update our &ldquo;forward-looking statements,&rdquo; and the estimates and assumptions within them, at any time or
for any reason. In particular, the following factors, among others, could cause actual results to differ materially from those
described in the &ldquo;forward-looking statements&rdquo;:</P>



<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">our continued operating and net losses in the future;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">our need for additional capital for our operations and to fulfill our business plans;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the effect of COVID-19;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">dependency on our ability, and the ability of our contract manufacturers, to timely procure electronic
components;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the potential ineffectiveness of our strategic focus on power supply solution competencies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">dependency on developer partners for the development of some of our custom design products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">dependency on sales of our legacy products for a meaningful portion of our revenues;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the possible failure of our custom product development efforts to result in products which meet
customers&rsquo; needs or such customers&rsquo; failure to accept such new products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">our ability to attract, retain and motivate key personnel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">dependence on a few major customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">dependence on the electronic equipment industry;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">reliance on third-party subcontract manufacturers to manufacture certain aspects of the products
sold by us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">reduced profitability as a result of increased competition, price erosion and product obsolescence
within the industry;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">our ability to establish, maintain and expand its OEM relationships and other distribution channels;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">our inability to procure necessary key components for its products, or the purchase of excess or
the wrong inventory;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">variations in operating results from quarter to quarter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">dependence on international sales and the impact of certain governmental regulatory restrictions
on such international sales and operations; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the risk factors included in our most recent filings with the SEC, including, but not limited to,
our Forms 10-K and 10-Q. All filings are also available on our website at&nbsp;<U>www.dpwholdings.com</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABOUT THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
selected information contained in other parts of this prospectus. Because it is a summary, it does not contain all of the information
that you should consider in making your investment decision. Before investing in our securities, you should read the entire prospectus
carefully, including the information set forth under the heading &ldquo;Risk Factors.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;Company Overview</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">DPW Holdings, Inc.
is a diversified holding company that owns operating subsidiaries and divisions engaged in a number of diversified business operations
including the defense, aerospace, commercial, health/medical, finance and commercial lending sectors. Our largest subsidiary is
Gresham Worldwide, which provides advanced bespoke military and commercial applications. We began implementing our strategy in
late 2016 led by our Chairman and CEO Milton &ldquo;Todd&rdquo; Ault, III and Vice Chairman and President William B. Horne. DPW
is presently led by an Executive Committee, the members of which are Messrs. Ault and Horne and Henry Nisser, our Executive Vice
President and General Counsel.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate as a holding
company with operations conducted primarily through our subsidiaries. We conduct our activities in a manner so as not to be deemed
an investment company under the Investment Company Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;). Generally,
this means that we do not invest or intend to invest in securities as our primary business and that no more than 40% of our total
assets will be invested in investment securities as such term is defined in the Investment Company Act. Pursuant to the Investment
Company Act, companies such as our subsidiary Digital Power Lending, LLC (&ldquo;DP Lending&rdquo;) are excluded from the definition
of an investment company since its business consists of making small loans and industrial banking. We also maintain a large investment
in Avalanche International, Corp., <FONT STYLE="color: #231F20">which does business as MTIX International.</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Originally, we were
primarily a solution-driven organization that designed, developed, manufactured and sold high-grade customized and flexible power
system solutions for the medical, military, telecom and industrial markets. Although we are actively seeking growth through acquisitions,
we will continue to focus on high-grade and custom product designs for the commercial, medical and military/defense markets, where
customers demand high density, high efficiency and ruggedized products to meet the harshest and/or military mission critical operating
conditions.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have operations
located in Europe through our wholly-owned subsidiary, Gresham Power Electronics (formerly Digital Power Limited) (&ldquo;Gresham
Power&rdquo;), Salisbury, England. Gresham Power designs, manufactures and sells power products and system solutions mainly for
the European marketplace, including power conversion, power distribution equipment, DC/AC (direct current/active current) inverters
and UPS (uninterrupted power supply) products. Our European defense business is specialized in the field of naval power distribution
products.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>Recent Events</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Reorganization
of Our Corporate Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing in October
and continuing through July 2020, we reorganized our corporate structure pursuant to a series of transactions among our company
and our directly and indirectly-owned subsidiaries. The purpose of the reorganization was to align our various businesses by the
products and services that constitute the majority of each subsidiaries&rsquo; revenues. As a result of the foregoing transactions,
our corporate structure is as follows:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="p4_chart.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 7, 2020,
we formed Coolisys Technologies Corp. (&ldquo;CTC&rdquo;) in order to hold Digital Power Corporation. Coolisys is presently owned
by GWW and owns Microphase Corporation, Gresham Power Electronics and Enertec Systems. We may dispose of Coolisys in the future,
leaving GWW as the direct owner of the three foregoing subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Other Matters</I></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">In
January 2018, we formed Super Crypto Mining, Inc., a wholly-owned subsidiary, which recently changed its name to Digital Farms,
Inc. (&ldquo;DFI&rdquo;). DFI was established to operate our newly formed cryptocurrency business, which mined a variety of digital
currency for our own account. These cryptocurrencies include Bitcoin, Litecoin and Ethereum.&nbsp;We made the decision to discontinue
DFI&rsquo;s operations in the first quarter of 2020.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
May 23, 2018, DP Lending entered into and closed a securities purchase agreement with I. AM, Inc. (&ldquo;I. AM&rdquo;). <FONT STYLE="background-color: white">I.
AM&rsquo;s operations were discontinued in the first quarter of 2020.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 2, 2020,
we entered into an At-The-Market Issuance Sales Agreement (the &ldquo;2020 ACM Sales Agreement&rdquo;) with Ascendiant Capital
Markets, LLC to sell shares of common stock having an aggregate offering price of up to $8,975,000 from time to time, through an
&ldquo;at the market offering&rdquo; program (the &ldquo;2020 ACM ATM Offering&rdquo;). The offer and sale of shares of common
stock from the 2020 ACM ATM Offering was made pursuant to our effective &ldquo;shelf&rdquo; registration statement on Form&nbsp;S-3
and an accompanying base prospectus contained therein (Registration Statement No.&nbsp;333-222132) which became effective on January
11, 2018. Through November 20, 2020, we had received gross proceeds of $8,953,354 through the sale of 4,906,340 shares of common
stock from the 2020 ACM ATM Offering.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 5, 2020,
we received $2,000,000 from Esousa and on October 22, 2020, we issued to Esousa a promissory note in the principal face amount
of $2,000,000, with an interest rate of 13%. The outstanding principal face amount, plus any accrued and unpaid interest, is due
by November 3, 2020, or as otherwise provided in accordance with the terms set forth therein. In connection therewith, we delivered
to Esousa a warrant to purchase 729,927 shares of common stock at an exercise price of $3.01. The exercise of the warrant is subject
to approval of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 27, 2020,
we issued to Esousa two unsecured promissory notes in the aggregate principal face amount of $1,200,000, of which $850,000 was
received prior to September 30, 2020. The principal amount of $850,000 of the first note dated October 27, 2020, together with
all accrued unpaid interest at an annual rate of 14%, is due and payable on December 28, 2020. The principal amount of $350,000
of the second note dated October 27, 2020, together with all accrued unpaid interest at an annual rate of 14%, is due and payable
on January 7, 2021. In connection with the two promissory notes, we delivered to the Esousa (i) a warrant dated October 27, 2020,
to purchase 425,000 shares of common stock at an exercise price of $2.20, and (ii) a warrant dated October 27, 2020, to purchase
148,936 shares of common stock at an exercise price of $2.59. The exercise of the warrants is subject to approval of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 9, 2020,
our <FONT STYLE="color: #231F20">wholly-owned subsidiary </FONT>Gresham Worldwide, Inc. (&ldquo;GWW&rdquo;) entered into a stock
purchase agreement with Tabard Holdings Inc., a Delaware corporation and wholly owned subsidiary of GWW (&ldquo;Tabard&rdquo;),
the legal and beneficial owners (the &ldquo;Sellers&rdquo;) of 100% of the issued shares in the capital of Relec Electronics Ltd.,
a corporation organized under the laws of England and Wales (&ldquo;Relec&rdquo;), and Peter Lappin, in his capacity as the representative
of the Sellers.&nbsp;&nbsp;Upon the terms and subject to the conditions set forth in the stock purchase agreement, Tabard agreed
to acquire Relec pursuant to the stock purchase agreement whereby the Sellers will sell to Tabard (i) 100% of the issued shares
of Relec. The purchase price is approximately &pound;3,000,000 plus an amount equal to Relec&rsquo;s cash balance immediately prior
to closing of the acquisition. Tabard has paid the sum of $500,000 to an escrow as a deposit toward payment of the purchase price.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 19, 2020,
we issued to Esousa and two other institutional investors unsecured promissory notes in the aggregate principal face amount of
$2,250,000, with an interest rate of 12%. The outstanding principal face amount, plus any accrued and unpaid interest, is due by
February 18, 2021, or as otherwise provided in accordance with the terms set forth therein. In connection therewith, we delivered
warrants to purchase an aggregate of 1,323,531 shares of common stock at an exercise price of $1.87, subject to adjustments. Exercise
of the warrants is subject to approval of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Settlement of Derivative Litigation</I></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 24, 2020,
we entered into a definitive settlement agreement (the &ldquo;Settlement Agreement&rdquo;) intended to settle the previously disclosed
derivative litigation captioned <I>Ethan Young and Greg Young, Derivatively on Behalf of Nominal Defendant, DPW Holdings, Inc.
v. Milton C. Ault, III, Amos Kohn, William B. Horne, Jeff Bentz, Mordechai Rosenberg, Robert O. Smith, and Kristine Ault and DPW
Holdings, Inc., as the nominal defendant</I> (Case No. 18-cv-6587) (as amended on March 11, 2019, the &ldquo;Amended Complaint&rdquo;)
against us and certain of our officers and directors pending in the United States District Court for the Central District of California
(the &ldquo;Court&rdquo;). As previously disclosed, the Amended Complaint alleges violations including breaches of fiduciary duties
and unjust enrichment claims based on the previously pled transactions.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 15, 2020,
the Court issued an Order (the &ldquo;Order&rdquo;) approving a Motion for Preliminary Approval of Settlement in the Derivative
Action. On July 16, 2020, the Court issued an Order (the &ldquo;Final Order&rdquo;) approving a Motion for Final Approval of Settlement
in the Derivative Action filed against DPW as a Nominal Defendant and its directors who served on its board of directors on July
31, 2018 who were not dismissed from the action as a result of the Court&rsquo;s partial grant of the Motion.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the terms of the Final Order, the Board has adopted certain resolutions and amendments to our committee charters and/or bylaws,
to ensure adherence to certain corporate governance policies (collectively, the &ldquo;Reforms&rdquo;). The Final Order further
provides that such Reforms shall remain in effect for a period of no less than five (5) years and shall be subject to any of the
following: (a) a determination by a majority of the independent directors that the Reforms are no longer in our best interest,
including, but not limited to, due to circumstances making the Reforms no longer applicable, feasible, or available on commercially
reasonable terms, or (b) modifications which we reasonably believe are required by applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Settlement Agreement, the parties have agreed upon a payment of attorneys&rsquo; fees in the amount of $600,000, which sum
shall be payable by our directors &amp; officers liability insurance. The Settlement Agreement contains no admission of wrongdoing.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have always maintained
and continue to believe that neither we nor our current or former directors engaged in any wrongdoing or otherwise committed any
violation of federal or state securities laws or any other laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Impact of Coronavirus
on Our Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
March 16, 2020, to try and mitigate the spread of the novel coronavirus, San Diego County health officials issued orders mandating
that all restaurants must end dine-in services. As a result of these temporary closures by the San Diego County health officials
and the deteriorating business conditions at both our cryptocurrency mining and restaurant businesses, management concluded that
discontinuing these operations was ultimately in our best interest. Although we have ceased operations at Digital Farms, since
the assets and operations have not yet been abandoned, sold or distributed, these assets do not yet meet the requirement for presentation
as discontinued operations. However, management determined that the permanent closing of the restaurant operations met the criteria
for presentation as discontinued operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
March 2020, the World Health Organization declared the outbreak of a novel coronavirus (&ldquo;COVID-19&rdquo;) as a pandemic which
continues to spread throughout the United States and the World. We are monitoring the outbreak of COVID-19 and the related business
and travel restrictions and changes to behavior intended to reduce its spread, and its impact on operations, financial position,
cash flows, inventory, supply chains, customer purchasing trends, customer payments, and the industry in general, in addition to
the impact on our employees. Due to the rapid development and fluidity of this situation, the magnitude and duration of the pandemic
and its impact on our operations and liquidity is uncertain as of the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">However,
our business has been disrupted and materially adversely affected by the recent outbreak of COVID-19. We are still assessing our
business operations and system supports and the impact COVID-19 may have on our results and financial condition, but there can
be no assurance that this analysis will enable us to avoid part or all of any impact from the spread of COVID-19 or its consequences,
including downturns in business sentiment generally or in our sectors in particular.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
operations are located in Alameda County, CA, Orange County, CA, Fairfield County, CT, the United Kingdom, Israel and members of
our senior management work in Seattle, WA and New York, NY. We have been following the recommendations of local health authorities
to minimize exposure risk for our employees, including the temporary closures of our offices and having employees work remotely
to the extent possible, which has to an extent adversely affected their efficiency. For more information, see &ldquo;Risk Factors
&ndash; We face business disruption and related risks resulting from the recent outbreak of the novel coronavirus . . . .&rdquo;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our corporate name
is DPW Holdings, Inc. for both legal and commercial purposes. Our principal address is 201 Shipyard Way, Suite E, Newport Beach,
CA 92663. Our phone number is (949) 444-5464. Our website is www.dpwholdings.com. The information on our website does not constitute
part of this prospectus.&nbsp; We have included our website address as a factual reference and do not intend it to be an active
link to our website.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Offering</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: justify; text-indent: 0.5in">The following
summary is provided solely for your convenience and is not intended to be complete. You should read the full text and more specific
details contained elsewhere in this prospectus. For a more detailed description of our common stock, see &ldquo;<I>Description
of Our Securities.&rdquo;</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; width: 35%"><FONT STYLE="font-size: 10pt"><B>Securities Offered by us:</B>&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 64%; text-align: justify"><FONT STYLE="font-size: 10pt">5,061,289 shares of our common stock, consisting of up to 155,660 shares of common stock issuable upon conversion of the JLA Note and up to 4,905,629 shares of common stock issuable upon exercise of Warrants</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Common Stock outstanding before this <BR>
offering:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">18,487,902 shares</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Common Stock to be outstanding after this <BR>
offering (assuming full exercise and <BR>
conversion):</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">23,549,191 shares</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Use of Proceeds:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We will not receive any of the proceeds from the sale of common stock by the selling stockholders, though we will receive proceeds in the event of any warrant exercise for cash. See &ldquo;<I>Use of Proceeds</I>.&rdquo;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Plan of Distribution:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The shares may be offered and sold from time to time by the selling stockholder named herein through public or private transactions at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. See &ldquo;<I>Plan of Distribution.&rdquo;</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NYSE American Symbol</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">DPW</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt"><B>Risk Factors:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Investing in our securities is highly speculative and involves a significant degree of risk.&nbsp;&nbsp;See &ldquo;Risk Factors&rdquo; and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our securities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The number of shares
of common stock that will be outstanding after this offering set forth above is based on 18,487,902 shares of common stock outstanding
as of November 23, 2020, and excludes the following:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">695,004 shares of common stock issuable upon the conversion of outstanding convertible debt instruments at conversion prices of between $1.28 per share and $8.80 per share;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4,235,168 shares of common stock issuable upon the exercise of outstanding warrants at an exercise prices of between $0.00 per share and $2,000 per share;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">950 shares of common stock issuable upon the exercise of stock options at a weighted average exercise prices of $578 per share, all of which were issued under the 2016 Stock Incentive Plan or the 2017 Stock Incentive Plan; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3,125 shares of common stock reserved for issuance under our Amended and Restated 2018 Stock Incentive Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise specifically
stated, all information in this prospectus assumes no exercise of the outstanding options or warrants described above.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">An investment
in our securities is speculative and involves a high degree of risk. Our business, financial condition or results of operations
could be adversely affected by any of these risks. You should carefully consider the risks described below and those risks set
forth in the reports that we file with the SEC and that we incorporate by reference into this prospectus, before deciding to invest
in our securities. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties
not presently known to us or that we currently deem immaterial may also affect our operations. Past financial performance may not
be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future
periods. If any of these risks actually occurs, our business, business prospects, financial condition or results of operations
could be seriously harmed. This could cause the trading price of our shares of common stock to decline, resulting in a loss of
all or part of your investment. Please also read carefully the section above entitled &ldquo;Disclosure Regarding Forward-Looking
Statements.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Company</U></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have historically incurred significant
losses and our financial situation creates doubt whether we will continue as a going concern</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have historically
experienced operating and net losses and anticipate continuing to experience such losses in the future. For the years ended December
31, 2019 and 2018, we had an operating loss of $26,941,797 and $19,605,456 and net losses of $32,913,412 and $32,233,881, respectively.
As of December 31, 2019 and 2018, we had a working capital deficiency of $19,150,075 and $18,445,302, respectively. There are no
assurances that we will be able to achieve a level of revenues adequate to generate sufficient cash flow from operations or obtain
additional financing through private placements, public offerings and/or bank financing necessary to support our working capital
requirements. To the extent that funds generated from any private placements, public offerings and/or bank financing are insufficient,
we will have to raise additional working capital. No assurance can be given that additional financing will be available, or if
available, will be on acceptable terms. These conditions raise substantial doubt about our ability to continue as a going concern.
If adequate working capital is not available we may be forced to discontinue operations, which would cause investors to lose their
entire investment.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to continue to incur losses for the foreseeable future and need to raise additional capital to continue business development
initiatives and to support our working capital requirements. However, if we are unable to raise additional capital, we may be required
to curtail operations and take additional measures to reduce costs, including reducing our workforce, eliminating outside consultants
and reducing legal fees in order to conserve cash in amounts sufficient to sustain operations and meet our obligations. As a result
of these financing uncertainties, during the year ended December 31, 2019, we recognized that our dependence on ongoing capital
requirements to fund our operations raise substantial doubt about our ability to continue as a going concern. Our ongoing capital
requirements have only increased since then, meaning that substantial doubt about our ability to continue as a going concern remains
and will likely do so for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We will need
to raise additional capital to fund our operations in furtherance of our business plan.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Until
we are profitable, we will need to quickly raise additional capital in order to fund our operations in furtherance of our business
plan. The proposed financing may include shares of common stock, shares of preferred stock, warrants to purchase shares of common
stock or preferred stock, debt securities, units consisting of the foregoing securities, equity investments from strategic development
partners or some combination of each. Any additional equity financings may be financially dilutive to, and will be dilutive from
an ownership perspective to our stockholders, and such dilution may be significant based upon the size of such financing. Additionally,
we cannot assure that such funding will be available on a timely basis, in needed quantities, or on terms favorable to us, if at
all.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have substantial amounts of indebtedness.
This indebtedness and the covenants contained in our loan documents with senior creditors substantially limit our financial and
operating flexibility</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
a number of loan documents, including security and similar agreements, with senior lenders (the &ldquo;Senior Lenders&rdquo;).
These loan documents (the &ldquo;Senior Loan Documents&rdquo;) grant priority security interests in all of our assets to the Senior
Lenders. Such Senior Loan Documents contain restrictions that substantially limit our financial flexibility. These Senior Loan
Documents place limits on our ability to (i) incur additional indebtedness even if such indebtedness is subordinated to the debt
instruments issued to the Senior Lenders, and (ii) grant security to third persons, among other matters. These restrictions limit
the Company&rsquo;s ability to finance its future operations and capital needs. Absent the consent of the Senior Lenders, we would
be unable to, among other things, obtain additional debt to raise additional capital, implement our business strategy, establish
corporate infrastructure and in any other way fund the development of its business. In addition, our substantial indebtedness could
require us to dedicate a substantial portion of our cash flow from the anticipated operations to making payments on our indebtedness
and other liabilities, which would limit the availability of funds for working capital and other general corporate purposes; limit
our flexibility in reacting to changes in the various industries in which we or any of our subsidiaries operates or in our competitive
environment; place us at a competitive disadvantage compared to those of our competitors who have less debt than we do, and limit
our ability to borrow additional funds and increase the costs of any such additional borrowings. If we are unable to pay our debts,
we would become insolvent.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Servicing our debt will require a significant
amount of cash, and we may not have sufficient cash flow from our business to pay our debt. We have defaulted on certain prior
repayment obligations.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to make
scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the DPW Notes, depends on
our future performance, which is subject to economic, financial, competitive and other factors beyond our control. In addition,
we have defaulted on certain prior repayment obligations as set forth below:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">On March 23, 2018, we entered into a securities purchase agreement pursuant to which we issued
a note in the amount of $1,000,000 to an investor. Pursuant to the terms of the note, we were required to pay interest on a monthly
basis. The maturity date of this note was June 22, 2018. We did not pay the interest on a timely basis or pay the note in full
on the maturity date. On July 3, 2019, we reached an agreement with the investor to repay the note under renegotiated terms with
a maturity date of January 22, 2020. This note was subsequently acquired by Esousa. As of the filing date of this prospectus, the
current principal amount outstanding on the note is $632,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">On September 21, 2018, we entered into a securities purchase agreement pursuant to which we issued
a note in the amount of $526,316 to an investor. The maturity date of this note was December 31, 2018. We did not pay the principal
or accrued interest in full on the maturity date. On July 2, 2019, we entered into an exchange agreement with the investor pursuant
to which, in exchange for the note issued by us to the investor, we sold to the investor a new convertible promissory note in the
principal amount of $783,031 with an interest rate of 12% per annum and a maturity date of December 31, 2019. On September 26,
2019, principal and interest on the 12% Convertible Note was exchanged for a convertible promissory note in the principal amount
of $815,218 with an interest rate of 12% per annum and a maturity date of December 31, 2019. Further, on February 5, 2020, we entered
into an exchange agreement with the investor pursuant to which, in exchange for the September 26, 2019 note issued by us to the
investor, we sold to the investor a new convertible promissory note in the principal amount of $295,000 and a new promissory note
in the principal amount of $585,919. Both of these notes have an interest rate of 12% per annum and a maturity date of December
31, 2019. We issued 203,448 shares of our common stock on February 25, 2020 in satisfaction of the February 5, 2020 convertible
promissory note.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">During 2018, we&nbsp;received funding as a result of entering&nbsp;into multiple Agreements for
the Purchase and Sale of Future Receipts (collectively, the &ldquo;Agreements on Future Receipts&rdquo;) pursuant to which we sold
in the aggregate $5,632,400 in future receipts for a purchase price in the amount of $4,100,000. Pursuant to the terms of the Agreements
on Future Receipts, we were required to make payments on a daily basis until the balance of the amount sold was fully repaid. We
did not make these daily payments on a timely basis. We reached an agreement with the investor to repay the Agreements on Future
Receipts under renegotiated terms. As of the filing date of this prospectus, the amount outstanding on the Agreements on Future
Receipts is $1,588,563.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">On November 28, 2018, <I>Blockchain Mining Supply and Services, Ltd</I>, a vendor who sold computers
to our subsidiary Digital Farms, Inc. (t/k/a Super Crypto Mining, Inc.), filed in the United States District Court for the Southern
District of New York against us and our subsidiary (Case No. 18-cv-11099). The Complaint asserted claims for breach of contract
and promissory estoppel against us and our subsidiary arising from the subsidiary&rsquo;s failure to satisfy a purchase agreement.&nbsp;
The Complaint seeks damages in the amount of $1,388,495, which approximates the amount of the reserve that we have established.
To date, the Court has not set a briefing schedule in connection with our anticipated motion to dismiss.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business may not
generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we
are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring
debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness
will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities
or engage in these activities on desirable terms, which could result in a default on our debt obligations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we default on secured debt instruments,
we may be required to repay the principal and accrued unpaid interest due thereon, together with additional penalties.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we do not timely
cure an event of default under the secured debt instruments, whether or not convertible, the holder(s) may accelerate all of our
repayment obligations and take control of our pledged assets, potentially requiring us to renegotiate the secured debt instruments
on terms less favorable to us or to immediately cease operations. Further, if we are liquidated, the holders&rsquo; rights to repayment
would be senior to the rights of the holders of our common stock to receive any proceeds from the liquidation. Any declaration
by the holders of an event of default could significantly harm our business and prospects and could cause the price of our common
stock to decline. If we raise any additional debt financing, the terms of such additional debt could further restrict our operating
and financial flexibility.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We face business
disruption and related risks resulting from the continuing impact of the novel coronavirus (&ldquo;COVID-19&rdquo;), which could
have a material adverse effect on our business and results of operations and curtail our ability to raise financing.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business has been
disrupted and materially adversely affected by the recent outbreak of COVID-19. As a result of measures imposed by the governments
in affected regions, businesses and schools have been suspended due to quarantines intended to contain this outbreak and many people
have been forced to work from home in those areas. The spread of COVID-19 from China to other countries has resulted in the Director
General of the World Health Organization declaring the outbreak of COVID-19 as a Public Health Emergency of International Concern,
based on the advice of the Emergency Committee under the International Health Regulations (2005), and the Centers for Disease Control
and Prevention in the U.S. issued a warning on February 25, 2020 regarding the likely spread of COVID-19 to the U.S. While the
COVID-19 outbreak is still in its early stages, international stock markets have begun to reflect the uncertainty associated with
the slow-down in the American, Israeli and UK economies and the reduced levels of international travel experienced since the beginning
of January and the significant decline in the Dow Industrial Average at the end of February 2020 was largely attributed to the
effects of COVID-19. We are still assessing our business operations and system supports and the impact COVID-19 may have on our
results and financial condition, but there can be no assurance that this analysis will enable us to avoid part or all of any impact
from the spread of COVID-19 or its consequences, including downturns in business sentiment generally or in our sectors in particular.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="color: #333333">Our
operations are located in Alameda County, CA, Orange County, CA, Fairfield County, CT, the United Kingdom, Israel and members of
our senior management work in Seattle, WA and New York, NY, which is also the location of the </FONT>offices of the Company&rsquo;s
independent auditor<FONT STYLE="color: #333333">. </FONT>We have been following the recommendations of local health authorities
to minimize exposure risk for its employees for the past several weeks, including the temporary closures of our offices and having
employees work remotely to the extent possible<FONT STYLE="color: #333333">, which has to an extent adversely affected their efficiency.
</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Updates by business unit are as follows:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">DPW Holdings&rsquo; corporate headquarters, located in Newport Beach, CA, has begun working remotely,
based on the occupancy and social distancing order from the Orange County Health Officer (http://www.ochealthinfo.com/phs/about/epidasmt/epi/dip/prevention/novel_coronavirus).
The headquarters staff has tested the secure remote access systems and technology infrastructure to adjust working arrangements
for its employees and believes it has adequate internal communications system and can remain operational with a remote staff.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Coolisys Technologies Corp., currently located in Milpitas, CA, decreased the number of its employees
working at its prior site in Fremont, CA for 14 weeks as a result of the Alameda County Public Health Department&rsquo;s order
to cease all activities at facilities located within the County.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Microphase Corporation, located in Shelton, CT, has developed an emergency plan to ensure that
its mission critical manufacturing and logistical functions are up and running. Microphase has implemented additional steps to
ensure a higher level of cleanliness in its facility. Employees at greater risk of major health issues from COVID-19 are not required
to work on site. The crisis management team meets regularly to monitor the situation, and modifies and communicates the plan as
the need arises. Once the COVID-19 crisis has passed, the team will work on transitioning Microphase back to normal operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Gresham Power Electronics Limited, located in Salisbury, UK, suspended production operations on
March 19, 2020 until June of 2020 and recently suspended such operations in November of 2020.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Enertec Systems 2001 Ltd., located in Karmiel, Israel, has been granted a waiver by the Israeli
government to remain open to complete key projects that impact national security. Approximately 50% of the Enertec workforce is
working remotely.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Due to the unprecedented
market conditions domestically and internationally, and the effect COVID-19 has had and will continue to have on the Company&rsquo;s
operations and financial performance, the extent of which is not currently known, the Company is temporarily suspending guidance
for 2020. We will monitor the situation rigorously and provide business updates as circumstances warrant and resume providing guidance
on our business when management believes that such information would be both reliable and substantively informative.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">The
duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted
at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions and
the impact of these and other factors on our employees, customers, partners and vendors. If we are not able to respond to and manage
the impact of such events effectively, our business will be harmed.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">As
noted above, we rely to a great extent on external financing to fund our operations. The outbreak of COVD-19 has had a materially
adverse impact on our ability to raise financing for our operations. Unless investors&rsquo; outlook improves dramatically in the
near future, it will further inhibit our ability to raise the funds we need to sustain our operations. No assurance can be given
that additional financing will be available, or if available, will be on acceptable terms.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our limited operating history makes
it difficult to evaluate our future business prospects and to make decisions based on our historical performance</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although our executive
officers have been engaged in the industries in which we operate for varying degrees of time, we did not begin operations of our
current business until recently. We have a very limited operating history in our current form, which makes it difficult to evaluate
our business on the basis of historical operations. As a consequence, it is difficult, if not impossible, to forecast our future
results based upon our historical data. Reliance on our historical results may not be representative of the results we will achieve,
and for certain areas in which we operate, principally those unrelated to defense contracting, will not be indicative at all. Because
of the uncertainties related to our lack of historical operations, we may be hindered in our ability to anticipate and timely adapt
to increases or decreases in sales, product costs or expenses. If we make poor budgetary decisions as a result of unreliable historical
data, we could be less profitable or incur losses, which may result in a decline in our stock price.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We have an evolving business model, which increases the complexity
of our business.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business model
has evolved in the past and continues to do so. In prior years we have added additional types of services and product offerings
and in some cases we have modified or discontinued those offerings. We intend to continue to try to offer additional types of products
or services, and we do not know whether any of them will be successful. From time to time we have also modified aspects of our
business model relating to our product mix. We do not know whether these or any other modifications will be successful. The additions
and modifications to our business have increased the complexity of our business and placed significant strain on our management,
personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions.
Future additions to or modifications of our business are likely to have similar effects. Further, any new business or website we
launch that is not favorably received by the market could damage our reputation or our brand. The occurrence of any of the foregoing
could have a material adverse effect on our business.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are a holding company whose subsidiaries
are given certain degree of independence and our failure to integrate our subsidiaries may adversely affect our financial condition</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have given our subsidiary
companies and their executives a certain degree of independence in decision-making. On the one hand, this independence may increase
the sense of ownership at all levels, on the other hand it has also increased the difficulty of the integration of operation and
management, which has resulted in increased difficulty of management integration. In the event we are not able to successfully
manage our subsidiaries this will result in operating difficulties and have a negative impact on our business.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Company and our independent auditors have expressed doubt
about our ability to continue as a going concern. If we do not continue as a going concern, investors will lose their entire investment</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In its report on our
financial statements included in our Annual Report for the fiscal year ended December 31, 2019, our independent auditors have expressed
doubt about our ability to continue as a going concern. Our ability to continue as a going concern is an issue raised as a result
of ongoing operating losses and a lack of financing commitments then in place to meet expected cash requirements. Our ability to
continue as a going concern is subject to our ability to generate a profit and/or obtain necessary funding from outside sources,
including obtaining additional funding from the sale of our securities, increasing sales or obtaining loans and grants from various
financial institutions where possible. If we do not continue as a going concern, investors will lose their entire investment.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We received an order and a subpoena
from the SEC in the investigation now known as &ldquo;<I>In the Matter of DPW Holdings, Inc</I></B>.<B><I>,&rdquo;</I> the consequences
of which are unknown.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We received an order
and related subpoena from the SEC that stated that the staff of the SEC is conducting an investigation now known as&nbsp;<I>&ldquo;In
the Matter of DPW Holdings, Inc.</I>,&rdquo; and that the subpoena was issued as part of an investigation as to whether we and
certain of our officers, directors, employees, partners, subsidiaries and/or affiliates, and/or other persons or entities, directly
or indirectly, violated certain provisions of the Securities Act and the Exchange Act, in connection with the offer and sale of
our securities. Although the order states that the SEC may have information relating to such alleged violations, the subpoena expressly
provides that the inquiry is not to be construed as an indication by the SEC or its staff that any violations of the federal securities
laws have occurred. We have produced documents in response to the subpoena. The SEC may in the future require us to produce additional
documents or information, or seek testimony from other members of our management team.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are unaware of the
scope or timing of the SEC&rsquo;s investigation. As a result, we do not know how the SEC&rsquo;s investigation is proceeding,
when the investigation will be concluded. We also are unable to predict what action, if any, might be taken in the future by the
SEC or its staff as a result of the matters that are the subject to its investigation or what impact, if any, the cost of continuing
to respond to subpoenas might have on our financial position, results of operations, or cash flows. We have not established any
provision for losses in respect of this matter In addition, complying with any such future requests by the SEC for documents or
testimony could distract the time and attention of our officers and directors or divert our resources away from ongoing business
matters. This investigation could result in significant legal expenses, the diversion of management&rsquo;s attention from our
business, damage to our business and reputation, and could subject us to a wide range of remedies, including an enforcement action
by the SEC. There can be no assurance that any final resolution of this and any similar matters will not have a material adverse
effect on our financial condition or results of operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>Our inability to successfully integrate new acquisitions
could adversely affect our combined business; our operations are widely disbursed.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
growth strategy through acquisitions is subject to various risks. On June 2, 2017, we acquired a majority interest in Microphase
and on May 23, 2018 we acquired Enertec Systems 2001 Ltd. (&ldquo;Enertec&rdquo;). Further, we have announced the entry into an
agreement whereby Gresham Worldwide will acquire Relec Electronics Ltd. from its present shareholders; however, we cannot presently
assure you that this transaction will be consummated. Our strategy and business plan are dependent on our ability to successfully
integrate Microphase&rsquo;s, Enertec&rsquo;s and our other acquired entities&rsquo; operations. In addition, while we are based
in Newport Beach, CA, Microphase&rsquo;s operations are located in Shelton, Connecticut, Enertec&rsquo;s operations are located
in Karmiel, Israel and Gresham Power&rsquo;s operations are located in Salisbury, England. These distant locations and others that
we may become involved with in the future will stretch our resources and management time. Further, failure to quickly and adequately
integrate all of these operations and personnel could adversely affect our combined business and our ability to achieve our objectives
and strategy. No assurance can be given that we will realize synergies in the areas we currently operate.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>If we make any additional acquisitions, they may disrupt
or have a negative impact on our business.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have plans to eventually
make additional acquisitions beyond Microphase and Enertec.&nbsp;Whenever we make acquisitions, we could have difficulty integrating
the acquired companies&rsquo; personnel and operations with our own. In addition, the key personnel of the acquired business may
not be willing to work for us. We cannot predict the effect expansion may have on our core business. Regardless of whether we are
successful in making an acquisition, the negotiations could disrupt our ongoing business, distract our management and employees
and increase our expenses. In addition to the risks described above, acquisitions are accompanied by a number of inherent risks,
including, without limitation, the following:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">difficulty of integrating acquired products, services or operations;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">potential disruption of the ongoing businesses and distraction of our management and the management
of acquired companies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">difficulty of incorporating acquired rights or products into our existing business;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">difficulties in disposing of the excess or idle facilities of an acquired company or business and
expenses in maintaining such facilities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">difficulties in maintaining uniform standards, controls, procedures and policies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">potential impairment of relationships with employees and customers as a result of any integration
of new management personnel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">potential inability or failure to achieve additional sales and enhance our customer base through
cross-marketing of the products to new and existing customers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">effect of any government regulations which relate to the business acquired; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">potential unknown liabilities associated with acquired businesses or product lines, or the need
to spend significant amounts to retool, reposition or modify the marketing and sales of acquired products or the defense of any
litigation, whether or not successful, resulting from actions of the acquired company prior to our acquisition.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business could
be severely impaired if and to the extent that we are unable to succeed in addressing any of these risks or other problems encountered
in connection with these acquisitions, many of which cannot be presently identified, these risks and problems could disrupt our
ongoing business, distract our management and employees, increase our expenses and adversely affect our results of operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No assurance can be given as to the successful expansion
of our operations.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our significant increase
in the scope and the scale of our operations, including the hiring of additional personnel, has resulted in significantly higher
operating expenses. We anticipate that our operating expenses will continue to increase. Expansion of our operations may also make
significant demands on our management, finances and other resources. Our ability to manage the anticipated future growth, should
it occur, will depend upon a significant expansion of our accounting and other internal management systems and the implementation
and subsequent improvement of a variety of systems, procedures and controls. We cannot assure that significant problems in these
areas will not occur. Failure to expand these areas and implement and improve such systems, procedures and controls in an efficient
manner at a pace consistent with our business could have a material adverse effect on our business, financial condition and results
of operations. We cannot assure that attempts to expand our marketing, sales, manufacturing and customer support efforts will succeed
or generate additional sales or profits in any future period. As a result of the expansion of our operations and the anticipated
increase in our operating expenses, along with the difficulty in forecasting revenue levels, we expect to continue to experience
significant fluctuations in its results of operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We may be unable to successfully expand
our production capacity, which could result in material delays, quality issues, increased costs and loss of business opportunities,
which may negatively impact our product margins and profitability</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Part of our future
growth strategy is to increase our production capacity to meet increasing demand for our goods. Assuming we obtain sufficient funding
to increase our production capacity, any projects to increase such capacity may not be constructed on the anticipated timetable
or within budget. We may also experience quality control issues as we implement any production upgrades. Any material delay in
completing these projects, or any substantial cost increases or quality issues in connection with these projects could materially
delay our ability to bring our products to market and adversely affect our business, reduce our revenue, income and available cash,
all of which could harm our financial condition.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we fail to establish and maintain
an effective system of internal control over financial reporting, we may not be able to report our financial results accurately
or prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation and adversely
impact the trading price of our common stock.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective internal
control over financial reporting is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide
reliable financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective
control environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any
current internal control deficiencies may adversely affect our financial condition, results of operations and access to capital.
We have carried out an evaluation under the supervision and with the participation of our management, including our principal executive
officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures
as of the end of the most recent period covered by this report. Based on the foregoing, our principal executive officer and principal
financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due
to the material weaknesses described below.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight
Board (&ldquo;PCAOB&rdquo;) Audit Standard No. 5, in internal control over financial reporting, such that there is a reasonable
possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely
basis. Management has identified the following material weaknesses which have caused management to conclude that as of December
31, 2019, our internal control over financial reporting (&ldquo;ICFR&rdquo;) was not effective at the reasonable assurance level:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We do not have sufficient resources in our accounting function, which restricts our ability to gather, analyze and properly review information related to financial reporting, including fair value estimates, in a timely manner. In addition, due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties during our assessment of our disclosure controls and procedures and concluded that the control deficiency that resulted represented a material weakness.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have inadequate controls to ensure that
        information necessary to properly record transactions is adequately communicated on a timely basis from non-financial personnel
        to those responsible for financial reporting. Management evaluated the impact of the lack of timely communication between non&ndash;financial
        and financial personnel on our assessment of our reporting controls and procedures and has concluded that the control deficiency
        represented a material weakness.</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We did not design or maintain effective
        general information technology (&ldquo;IT&rdquo;) controls over certain information systems that are relevant to the mitigation
        of the risk pertaining to the misappropriation of assets. Specifically, we did not design and implement p<FONT STYLE="background-color: white">rogram
        change management controls for certain financially relevant systems to ensure that IT program and data changes affecting the Company&rsquo;s
        (i) financial IT applications, (ii) digital currency mining equipment, (iii) digital currency hardware wallets, and (iv) underlying
        accounting records, are identified, tested, authorized and implemented appropriately.</FONT></P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Planned Remediation</I></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management,
in coordination with the input, oversight and support of our Board of Directors, has identified the measures below to strengthen
our control environment and internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
January 2018, we hired a new Chief Financial Officer and engaged the services of a financial accounting advisory firm. In September
2018, we hired a Chief Accounting Officer and in January 2019, we hired a Senior Vice President of Finance. Finally, in May 2019,
we hired an Executive Vice President and General Counsel. We have tasked these individuals with expanding and monitoring the Company&rsquo;s
internal controls, to provide an additional level of review of complex financial issues and to assist with financial reporting.
On October 7, 2019, we created an Executive Committee comprised of our Chief Executive Officer, President and Executive Vice President
and General Counsel. The Executive Committee meets on a daily basis to address the Company&rsquo;s critical needs and provide a
forum to approve transactions. Further, as we continue to expand our internal accounting department, the Chairman of the Audit
Committee will:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">assist with documentation and implementation of policies and procedures and monitoring of controls;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">review all anticipated transactions that are not considered in the ordinary course of business
to assist in the early identification of accounting issues and ensure that appropriate disclosures are made in our financial statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are currently working to improve and simplify our internal processes and implement enhanced controls, as discussed above, to address
the material weaknesses in our internal control over financial reporting and to remedy the ineffectiveness of our disclosure controls
and procedures. These material weaknesses will not be considered to be remediated until the applicable remediated controls are
operating for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>If our accounting
controls and procedures are circumvented or otherwise fail to achieve their intended purposes, our business could be seriously
harmed.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
evaluate our disclosure controls and procedures as of the end of each fiscal quarter, and are annually reviewing and evaluating
our internal control over financial reporting in order to comply with the SEC&rsquo;s rules relating to internal control over financial
reporting adopted pursuant to the Sarbanes-Oxley Act of 2002. Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate. If we fail to maintain effective internal control over financial reporting or our management does
not timely assess the adequacy of such internal control, we may be subject to regulatory sanctions, and our reputation may decline.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We face significant competition, including changes in pricing.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets for our
products are both competitive and price sensitive. Many competitors have significant financial, operations, sales and marketing
resources, plus experience in research and development, and compete with us by offering lower prices. Competitors could develop
new technologies that compete with our products to achieve a lower unit price. If a competitor develops lower cost superior technology
or cost-effective alternatives to our products and services, our business could be seriously harmed.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets for some
of our products are also subject to specific competitive risks because these markets are highly price competitive. Our competitors
have competed in the past by lowering prices on certain products. If they do so again, we may be forced to respond by lowering
our prices. This would reduce sales revenues and increase losses. Failure to anticipate and respond to price competition may also
impact sales and aggravate losses.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Many of our competitors are larger and
have greater financial and other resources than we do.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products compete
and will compete with similar if not identical products produced by our competitors. These competitive products could be marketed
by well-established, successful companies that possess greater financial, marketing, distribution personnel, and other resources
than we do. Using said resources, these companies can implement extensive advertising and promotional campaigns, both generally
and in response to specific marketing efforts by competitors. They can introduce new products to new markets more rapidly. In certain
instances, competitors with greater financial resources may be able to enter a market in direct competition with us, offering attractive
marketing tools to encourage the sale of products that compete with our products or present cost features that consumers may find
attractive.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Our growth strategy is subject to
a significant degree of risk.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
growth strategy through acquisitions involves a significant degree of risk. Some of the companies that we have identified as acquisition
targets or make a significant investment in may not have a developed business or are experiencing inefficiencies and incur losses.
Therefore, we may lose our investment in the event that these companies&rsquo; businesses do not develop as planned or that we
are unable to achieve the cost efficiencies or reduction of losses as anticipated.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further,
in order to implement our growth plan, we have hired additional staff and consultants to review potential investments and implement
our plan. As a result, we have substantially increased our infrastructure and costs. If we fail to quickly find new companies that
provide revenue to offset our costs, we will continue to experience losses. No assurance can be given that our product development
and investments will produce sufficient revenues to offset these increases in expenditures.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our business and operations are growing
rapidly. If we fail to effectively manage our growth, our business and operating results could be harmed</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have experienced,
and may continue to experience, rapid growth in our operations. This has placed, and may continue to place, significant demands
on our management, operational and financial infrastructure. If we do not manage our growth effectively, the quality of our products
and services could suffer, which could negatively affect our operating results. To effectively manage our growth, we must continue
to improve our operational, financial and management controls and reporting systems and procedures. These systems improvements
may require significant capital expenditures and management resources. Failure to implement these improvements could hurt our ability
to manage our growth and our financial position.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We are heavily dependent on our senior management, and a
loss of a member of our senior management team could cause our stock price to suffer</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we lose the services
of Milton C. Ault III, our Chairman and Chief Executive Officer, William B. Horne, our President, or Henry Nisser, our Executive
Vice President and General Counsel, and/or certain key employees, we may not be able to find appropriate replacements on a timely
basis, and our business could be adversely affected. Our existing operations and continued future development depend to a significant
extent upon the performance and active participation of these individuals and certain key employees. Although we have entered into
employment agreements with Messrs. Ault, Horne and Nisser, and we may enter into employment agreements with additional key employees
in the future, we cannot guarantee that we will be successful in retaining the services of these individuals. If we were to lose
any of these individuals, we may not be able to find appropriate replacements on a timely basis and our financial condition and
results of operations could be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We rely on highly skilled personnel
and the continuing efforts of our executive officers and, if we are unable to retain, motivate or hire qualified personnel, our
business may be severely disrupted.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our performance largely
depends on the talents, knowledge, skills, know-how and efforts of highly skilled individuals and in particular, the expertise
held by our Chairman and Chief Executive Officer, Milton C. Ault III. His absence, were it to occur, would materially and adversely
impact development and implementation of our projects and businesses. Our future success depends on our continuing ability to identify,
hire, develop, motivate and retain highly skilled personnel for all areas of our organization. Our continued ability to compete
effectively depends on our ability to attract, among others, new technology developers and to retain and motivate our existing
contractors. If one or more of our executive officers are unable or unwilling to continue in their present positions, we may not
be able to replace them readily, if at all. Therefore, our business may be severely disrupted, and we may incur additional expenses
to recruit and retain new officers. In addition, if any of our executives joins a competitor or forms a competing company, we may
lose some customers.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our operating results may vary from quarter to quarter.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operating results
have in the past been subject to quarter-to-quarter fluctuations, and we expect that these fluctuations will continue, and may
increase in magnitude, in future periods. Demand for our products is driven by many factors, including the availability of funding
for our products in our customers&rsquo; capital budgets. There is a trend for some of our customers to place large orders near
the end of a quarter or fiscal year, in part to spend remaining available capital budget funds. Seasonal fluctuations in customer
demand for our products driven by budgetary and other concerns can create corresponding fluctuations in period-to-period revenues,
and we therefore cannot assure you that our results in one period are necessarily indicative of our revenues in any future period.
In addition, the number and timing of large individual sales and the ability to obtain acceptances of those sales, where applicable,
have been difficult for us to predict, and large individual sales have, in some cases, occurred in quarters subsequent to those
we anticipated, or have not occurred at all. The loss or deferral of one or more significant sales in a quarter could harm our
operating results for such quarter. It is possible that, in some quarters, our operating results will be below the expectations
of public market analysts or investors. In such events, or in the event adverse conditions prevail, the market price of our common
stock may decline significantly.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We may be classified as an inadvertent investment company.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not engaged
in the business of investing, reinvesting, or trading in securities, and we do not hold ourselves out as being engaged in those
activities. Under the Investment Company Act, however, a company may be deemed an investment company under section 3(a)(1)(C) of
the Investment Company Act if the value of its investment securities is more than 40% of its total assets (exclusive of government
securities and cash items) on a consolidated basis.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our lending subsidiary,
Digital Power Lending, LLC (&ldquo;DP Lending&rdquo;), operates under California Finance Lending License #60DBO-77905. Per the
Investment Company Act of 1940 companies with substantially all their business confined to making small loans, industrial banking
or similar business, such as DP Lending, are excluded from the definition of an investment company.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have commenced digital
asset mining, the output of which is cryptocurrencies, which the SEC has indicated it deems a security. In the event that the digital
assets held by us exceed 40% of our total assets, exclusive of cash, we inadvertently become an investment company. An inadvertent
investment company can avoid being classified as an investment company if it can rely on one of the exclusions under the Investment
Company Act. One such exclusion, Rule 3a-2 under the Investment Company Act, allows an inadvertent investment company a grace period
of one year from the earlier of (a) the date on which an issuer owns securities and/or cash having a value exceeding 50% of the
issuer&rsquo;s total assets on either a consolidated or unconsolidated basis and (b) the date on which an issuer owns or proposes
to acquire investment securities having a value exceeding 40% of the value of such issuer&rsquo;s total assets (exclusive of government
securities and cash items) on an unconsolidated basis. We are putting in place policies that we expect will work to keep the investment
securities held by us at less than 40% of our total assets, which may include acquiring assets with our cash, liquidating our investment
securities or seeking a no-action letter from the SEC if we are unable to acquire sufficient assets or liquidate sufficient investment
securities in a timely manner.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As Rule 3a-2 is available
to a company no more than once every three years, and assuming no other exclusion were available to us, we would have to keep within
the 40% limit for at least three years after we cease being an inadvertent investment company. This may limit our ability to make
certain investments or enter into joint ventures that could otherwise have a positive impact on our earnings. In any event, we
do not intend to become an investment company engaged in the business of investing and trading securities.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Classification as an
investment company under the Investment Company Act requires registration with the SEC. If an investment company fails to register,
it would have to stop doing almost all business, and its contracts would become voidable. Registration is time consuming and restrictive
and would require a restructuring of our operations, and we would be very constrained in the kind of business we could do as a
registered investment company. Further, we would become subject to substantial regulation concerning management, operations, transactions
with affiliated persons and portfolio composition, and would need to file reports under the Investment Company Act regime. The
cost of such compliance would result in our incurring substantial additional expenses, and the failure to register if required
would have a materially adverse impact to conduct our operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We will not be able to successfully
execute our business strategy if we are deemed to be an investment company under the Investment Company Act.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. companies that
have more than 100 stockholders or are publicly traded in the U.S. and are, or hold themselves out as being, engaged primarily
in the business of investing, reinvesting or trading in securities are subject to regulation under the Investment Company Act.&nbsp;
Unless a substantial part of our assets consists of, and a substantial part of our income is derived from, interests in majority-owned
subsidiaries and companies that we primarily control, we may be required to register and become subject to regulation under the
Investment Company Act.&nbsp; If we were deemed to own but not operate one or more of our other subsidiaries, we would have difficulty
avoiding classification and regulation as an investment company.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we were deemed to
be, and were required to register as, an investment company, we would be forced to comply with substantive requirements under the
Investment Company Act, including limitations on our ability to borrow, limitations on our capital structure; restrictions on acquisitions
of interests in associated companies, prohibitions on transactions with affiliates, restrictions on specific investments, and compliance
with reporting, record keeping, voting, proxy disclosure and other rules and regulations.&nbsp; If we were forced to comply with
the rules and regulations of the Investment Company Act, our operations would significantly change, and we would be prevented from
successfully executing our business strategy.&nbsp; To avoid regulation under the Investment Company Act and related rules promulgated
by the SEC, we could need to sell bitcoin and other assets which we would otherwise want to retain and could be unable to sell
assets which we would otherwise want to sell.&nbsp; In addition, we could be forced to acquire additional, or retain existing,
income-generating or loss-generating assets which we would not otherwise have acquired or retained and could need to forgo opportunities
to acquire bitcoin and other assets that would benefit our business.&nbsp; If we were forced to sell, buy or retain assets in this
manner, we could be prevented from successfully executing our business strategy.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Securitization of our assets subjects us to various risks</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may securitize assets
to generate cash for funding new investments. We refer to the term securitize to describe a form of leverage under which a company
(sometimes referred to as an &ldquo;originator&rdquo; or &ldquo;sponsor&rdquo;) transfers income producing assets to a single-purpose,
bankruptcy-remote subsidiary (also referred to as a &ldquo;special purpose entity&rdquo; or &ldquo;SPE&rdquo;), which is established
solely for the purpose of holding such assets and entering into a structured finance transaction. The SPE would then issue notes
secured by such assets. The special purpose entity may issue the notes in the capital markets either publicly or privately to a
variety of investors, including banks, non-bank financial institutions and other investors. There may be a single class of notes
or multiple classes of notes, the most senior of which carries less credit risk and the most junior of which may carry substantially
the same credit risk as the equity of the SPE.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An important aspect
of most debt securitization transactions is that the sale and/or contribution of assets into the SPE be considered a true sale
and/or contribution for accounting purposes and that a reviewing court would not consolidate the SPE with the operations of the
originator in the event of the originator's bankruptcy based on equitable principles. Viewed as a whole, a debt securitization
seeks to lower risk to the note purchasers by isolating the assets collateralizing the securitization in an SPE that is not subject
to the credit and bankruptcy risks of the originator. As a result of this perceived reduction of risk, debt securitization transactions
frequently achieve lower overall leverage costs for originators as compared to traditional secured lending transactions.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the above description, to securitize loans, we may create a wholly owned subsidiary and contribute a pool of our assets to such
subsidiary. The SPE may be funded with, among other things, whole loans or interests from other pools and such loans may or may
not be rated. The SPE would then sell its notes to purchasers whom we would expect to be willing to accept a lower interest rate
and the absence of any recourse against us to invest in a pool of income producing assets to which none of our creditors would
have access. We would retain all or a portion of the equity in the SPE. An inability to successfully securitize portions of our
portfolio or otherwise leverage our portfolio through secured and unsecured borrowings could limit our ability to grow our business
and fully execute our business strategy, and could decrease our earnings, if any. However, the successful securitization of portions
of our portfolio exposes us to a risk of loss for the equity we retain in the SPE and might expose us to greater risk on our remaining
portfolio because the assets we retain may tend to be those that are riskier and more likely to generate losses. A successful securitization
may also impose financial and operating covenants that restrict our business activities and may include limitations that could
hinder our ability to finance additional loans and investments. The Investment Company Act may also impose restrictions on the
structure of any securitizations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interests we hold in
the SPE, if any, will be subordinated to the other interests issued by the SPE. As such, we will only receive cash distributions
on such interests if the SPE has made all cash interest and other required payments on all other interests it has issued. In addition,
our subordinated interests will likely be unsecured and rank behind all of the secured creditors, known or unknown, of the SPE,
including the holders of the senior interests it has issued. Consequently, to the extent that the value of the SPE's portfolio
of assets has been reduced as a result of conditions in the credit markets, or as a result of defaults, the value of the subordinated
interests we retain would be reduced. Securitization imposes on us the same risks as borrowing except that our risk in a securitization
is limited to the amount of subordinated interests we retain, whereas in a borrowing or debt issuance by us directly we would be
at risk for the entire amount of the borrowing or debt issuance.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also engage
in transactions utilizing SPEs and securitization techniques where the assets sold or contributed to the SPE remain on our balance
sheet for accounting purposes. If, for example, we sell the assets to the SPE with recourse or provide a guarantee or other credit
support to the SPE, its assets will remain on our balance sheet. Consolidation would also generally result if we, in consultation
with the SEC, determine that consolidation would result in a more accurate reflection of our assets, liabilities and results of
operations. In these structures, the risks will be essentially the same as in other securitization transactions but the assets
will remain our assets for purposes of the limitations described above on investing in assets that are not qualifying assets and
the leverage incurred by the SPE will be treated as borrowings incurred by us for purposes of our limitation on the issuance of
senior securities.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We may not be able to utilize our net operating loss carry
forwards.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2019,
we had Federal net operating loss carry forwards (&ldquo;NOLs&rdquo;) for income tax purposes of approximately $52,884,756. Approximately
$12,302,381 of NOLs generated prior to 2018 will begin to expire in 2020. The Coronavirus Aid, Relief, and Economic Security Act
signed in to law on March 27, 2020 provided that NOLs generated in a taxable year beginning in 2018, 2019, or 2020, may now be
carried back five years and forward indefinitely. In addition, the 80% taxable income limitation is temporarily removed, allowing
NOLs to fully offset net taxable income. However, we do not know if or when we will have any earnings and capital gains against
which we could apply these carry forwards.&nbsp; Furthermore, as a result of changes in the ownership of our common stock, our
ability to use our federal NOLs will be limited under Internal Revenue Code Section 382.&nbsp; State NOLs are subject to similar
limitations in many cases.&nbsp; As a result, our substantial NOLs may not have any value to us.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes in the U.S. tax and other laws and regulations may
adversely affect our business.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.S. government
may revise tax laws, regulations or official interpretations in ways that could have a significant adverse effect on our business,
including modifications that could reduce the profits that we can effectively realize from our international operations, or that
could require costly changes to those operations, or the way in which they are structured.&nbsp; For example, the effective tax
rates for most U.S. companies reflect the fact that income earned and reinvested outside the U.S. is generally taxed at local rates,
which may be much lower than U.S. tax rates.&nbsp; If we expand abroad and there are changes in tax laws, regulations or interpretations
that significantly increase the tax rates on non-U.S. income, our effective tax rate could increase and our profits could be reduced.&nbsp;
If such increases resulted from our status as a U.S. company, those changes could place us at a disadvantage to our non-U.S. competitors
if those competitors remain subject to lower local tax rates.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Related to Related Party Transactions</U></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There may be conflicts
of interest between our company and certain of our related parties and their respective directors and officers which might not
be resolved in our favor. More importantly, there may be conflicts between certain of our related parties and their respective
directors and officers which might not be resolved in our favor. These risks are set forth below appurtenant to the relevant related
party.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Ault &amp; Company</U></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our relationship with Ault &amp; Company
may enhance the difficulty inherent in obtaining financing for us as well as expose us to certain conflicts of interest.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this
prospectus, Ault &amp; Company, of which Milton C. Ault is the chief executive officer, beneficially owned 1,362,795 shares of
our common stock, consisting of 1,078,967 shares owned, 275,862 shares of common stock underlying the 8% Convertible Promissory
Note in the outstanding principal amount of $400,000 sold by us to Ault &amp; Company on February 5, 2020, assuming no conversion
of accrued, unpaid interest on this note, warrants to purchase 94 shares of common stock that are currently exercisable and shares
owned by Philou Ventures, of which Ault &amp; Company, Inc. is the Manager, consisting of: (i) 125,000 shares of Series B Preferred
Stock that are convertible into 2,232 shares of common stock, (ii) warrants to purchase 2,232 shares of common stock that are exercisable
within 60 days of the date hereof and (iii) 3,408 shares of common stock. Assuming Ault &amp; Company converted its note on the
date of this prospectus, Ault &amp; Company would own a number of shares of common stock equal to 7.3% of the number of shares
of common stock on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Ault &amp;
Company and our company are negotiating the terms of a proposed purchase by Ault &amp; Company of a certain number of shares of
Series C Preferred Stock. Presently, neither the number nor the terms of any such Series C Preferred Stock has been determined,
and any such purchase would have to be approved by our stockholders before Ault &amp; Company would be able to vote or convert
such shares of Series C Preferred Stock. Notwithstanding the presently indeterminate nature of any such acquisition of Series Preferred
Stock, you should be aware that the consummation of such a transaction, assuming the receipt by the Company of its stockholders
approval thereof, could substantially increase Ault &amp; Company&rsquo;s beneficial ownership of our shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Given the close relationship
between Ault &amp; Company on the one hand, and our company on the other, it is far from inconceivable that we could enter into
additional securities purchase agreements with Ault &amp; Company.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have relied
on Philou to finance us in the past, which no longer beneficially owns any meaningful number of our shares of common stock, and
anticipate that Ault &amp; Company may purchase shares of our Series C Preferred Stock under an agreement providing for the purchase
thereof, we cannot assure you that either Philou or Ault &amp; Company will assist us in the future. We would far prefer to rely
on these entities&rsquo; assistance compared to other sources of financing as the terms they provide us are in general more favorable
to us than we could obtain elsewhere. However, both Messrs. Ault and Horne could face a conflict of interest in that they serve
on the board of directors of each of Ault &amp; Company and our company. If they determine that an investment in our company is
not in Ault &amp; Company&rsquo;s best interest(s) we could be forced to seek financing from other sources that would not necessarily
be likely to provide us with equally favorable terms. It should be noted in this context that while Mr. Nisser does not serve as
a director of our company, he is its General Counsel and Executive Vice President as well as a director and the President of Ault
&amp; Company.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other conflicts of
interest between us, on the one hand, and Ault &amp; Company, on the other hand, may arise relating to commercial or strategic
opportunities or initiatives. Mr. Ault, as the controlling shareholder of Ault &amp; Company, may not resolve such conflicts in
our favor. For example, we cannot assure you that Ault &amp; Company would not pursue opportunities to provide financing to other
entities whether or not it currently has a relationship with such other entities. Furthermore, our ability to explore alternative
sources of financing other than Ault &amp; Company may be constrained due to Mr. Ault&rsquo;s vision for us and he may not wish
for us to receive any financing at all other than from entities that he controls.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Avalanche International Corp</U>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have lent a substantial amount of
funds to Avalanche, a related party, whose ability to repay us is subject to significant doubt and it may not be in our stockholders&rsquo;
best interest to convert the notes into shares of Avalanche common stock even if we had a reasonably viable means of doing so.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 6, 2017,
we entered into a Loan and Security Agreement with Avalanche (&ldquo;<B>AVLP Loan Agreement</B>&rdquo;) with an effective date
of August 21, 2017 pursuant to which we will provide Avalanche a non-revolving credit facility of up to $10,000,000 for a period
ending on August 21, 2021.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2019,
we had provided Avalanche with $9,595,079 pursuant to the non-revolving credit facility. The warrants issued in conjunction with
the non-revolving credit facility entitles us to purchase up to 19,190,158 shares of Avalanche common stock at an exercise price
of $0.50 per share for a period of five years. The exercise price of $0.50 is subject to adjustment for customary stock splits,
stock dividends, combinations or similar events. The warrants may be exercised for cash or on a cashless basis.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While Avalanche received
funds from a third party in the amount of $2,750,000 in early April of 2019 in consideration for its issuance of a convertible
promissory note to such third party (the &ldquo;<B>Third Party Note</B>&rdquo;), $2,676,220 was used to pay an outstanding receivable
due us and no amount was used to repay the debt Avalanche owes us pursuant to the AVLP Loan Agreement. There is doubt as to whether
Avalanche will be able to repay this amount on a timely basis, if at all, unless it generates significant net income from its operations
or receives additional financing from another source; even then, unless such financing consists solely of the issuance by Avalanche
of its equity securities, it will only add to the amount that Avalanche owes other parties, which would in all likelihood not be
provided unless we agreed to subordinate our right to repayment to such other third party source.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is currently
no liquid market for the Avalanche common stock. Consequently, even if we were inclined to convert the debt owed us by Avalanche
into shares of its common stock, our ability to sell such shares is severely limited. Avalanche is not current in its filings with
the SEC and is not required to register the shares of its common stock underlying the amount provided pursuant to the non-revolving
credit facility or any other loan arrangement we have made with Avalanche described above. Further, even if Avalanche were willing
to register such shares, it would not be permitted to do so until it has registered the shares of its common stock underlying the
Third Party Note.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, there
is considerable doubt as to whether Avalanche will ever have the ability to repay its debts to us, or if we convert the debt owed
us by Avalanche into shares of its common stock, our ability to convert such shares into cash through the sale of such shares would
be severely limited until such time, if ever, a liquid market for Avalanche&rsquo;s common stock develops. If we are unable to
recoup our investment in Avalanche in the foreseeable future or at all, such failure would have a materially adverse effect on
our financial condition and future prospects.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Originally, the loans we made to Avalanche
were secured by a lien on all of Avalanche&rsquo;s assets. Presently, we only have third priority interest.</B></P>





<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Originally, the loans
we made to Avalanche were secured by a lien on all of Avalanche&rsquo;s assets. When Avalanche entered into the Exchange Agreement
with MTIX (see below), the former owners of MTIX were granted a first priority interest in all of MTIX&rsquo;s assets, which constitute
virtually all of Avalanche&rsquo;s assets and reduced our interest to that of a second position, greatly diminishing its value.
When Avalanche issued the Third Party Note referred to above, it granted the third party a first priority security interest in
all its assets, to include those comprised of MTIX. Both we and the former owners of MTIX consented to the subordination of our
respective security interests. Since our security interests have been reduced to a third position, we will have no ability to use
Avalanche&rsquo;s assets to offset any default in Avalanche&rsquo;s debt obligations to us unless and until the two other security
interests are terminated, which would not occur until Avalanche&rsquo;s debts to the senior creditors have been repaid. We do not
anticipate that Avalanche will repay its debts to these creditors within the foreseeable future and will therefore have no recourse
should Avalanche default on its debts to us during this period of time. Any failure by Avalanche to repay us would therefore have
a materially adverse effect on our results of operations, financial condition and future prospects.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Milton C. Ault, III and William Horne,
our Chief Executive Officer and President, respectively, and two of our directors are directors of Avalanche. In addition, Philou
is the controlling stockholder of Avalanche.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Milton C. Ault, III
and William Horne, our Chief Executive Officer and President, respectively, and two of our directors are directors of Avalanche.
In addition, Philou is the controlling stockholder of Avalanche. Certain conflicts of interest between us, on the one hand, and
Avalanche, on the other hand, may arise relating to commercial or strategic opportunities or initiatives, in addition to the conflicts
related to the debt that Avalanche owes us. For example, Messrs. Ault and Horne may find it difficult to determine how to meet
their fiduciary duties to us as well as Avalanche, which could result in a less favorable result for us than would be the case
if they were solely directors of our company. Further, even if Messrs. Ault and Horne were able to successfully meet their fiduciary
obligations to us and Avalanche, the fact that are members of the board of directors of both companies could attenuate their ability
to focus on our business and best interests, possibly to the detriment of both companies. Mr. Ault&rsquo;s control of Philou through
Ault &amp; Company only enhances the risk inherent in having Messrs. Ault and Horne serve as directors of both our company and
Avalanche.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Overview</U></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Technology changes rapidly in our business,
and if we fail to anticipate new technologies, the quality, timeliness and competitiveness of our products will suffer.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rapid technology changes
in our industry require us to anticipate, sometimes years in advance, which technologies and/or distribution platforms our products
must take advantage of in order to make them competitive in the market at the time they are released. Therefore, we usually start
our product development with a range of technical development goals that we hope to be able to achieve. We may not be able to achieve
these goals, or our competition may be able to achieve them more quickly than we can. In either case, our products may be technologically
inferior to competitive products, or less appealing to consumers, or both. If we cannot achieve our technology goals within the
original development schedule of our products, then we may delay products until these technology goals can be achieved, which may
delay or reduce revenue and increase our development expenses. Alternatively, we may increase the resources employed in research
and development in an attempt to accelerate our development of new technologies, either to preserve our product launch schedule
or to keep up with our competition, which would increase our development expenses and adversely affect our operations and financial
condition.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are dependent upon our ability, and
our contract manufacturers&rsquo; ability, to timely procure electronic components.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because of the global
economy, many raw material vendors have reduced capacities, closed production lines and, in some cases, even discontinued their
operations. As a result, there is a global shortage of certain electronic or mineral components, which may extend our production
lead-time and our production costs. Some materials are no longer available to support some of our products, thereby requiring us
to search for cross materials or, even worse, redesign some of our products to support currently-available materials. Such redesign
efforts may require certain regulatory and safety agency re-submittals, which may cause further production delays. While we have
initiated actions that we believe will limit our exposure to such problems, the dynamic business conditions in many of our markets
may challenge the solutions that have been put in place, and issues may recur in the future.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, some of
our products are manufactured, assembled and tested by third party subcontractors and contract manufacturers located in Asia. While
we have had relationships with many of these third parties in the past, we cannot predict how or whether these relationships will
continue in the future. In addition, changes in management, financial viability, manufacturing demand or capacity, or other factors,
at these third parties could hurt our ability to manufacture our products.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our strategic focus on our custom power
supply solution competencies and concurrent cost reduction plans may be ineffective or may limit our ability to compete.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of our
strategic focus on custom power supply solutions, we will continue to devote significant resources to developing and manufacturing
custom power supply solutions for a large number of customers, where each product represents a uniquely tailored solution for a
specific customer&rsquo;s requirements. Failure to meet these customer product requirements or a failure to meet production schedules
and/or product quality standards may put us at risk with one or more of these customers. Moreover, changes in market conditions
and strategic changes at the direction of our customers may affect their decision to continue to purchase from us. The loss of
one or more of our significant custom power supply solution customers could have a material adverse impact on our revenues, business
or financial condition.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also implemented
a series of initiatives designed to increase efficiency and reduce costs. While we believe that these actions will reduce costs,
they may not be sufficient to achieve the required operational efficiencies that will enable us to respond more quickly to changes
in the market or result in the improvements in our business that we anticipate. In such event, we may be forced to take additional
cost-reducing initiatives, including those involving our personnel, which may negatively impact quarterly earnings and profitability
as we account for severance and other related costs. In addition, there is the risk that such measures could have long-term adverse
effects on our business by reducing our pool of talent, decreasing or slowing improvements in our products or services, making
it more difficult for us to respond to customers, limiting our ability to increase production quickly if and when the demand for
our solutions increases and limiting our ability to hire and retain key personnel. These circumstances could cause our earnings
to be lower than they otherwise might be.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We<FONT STYLE="color: red">&nbsp;</FONT>depend
upon a few major customers for a majority of our revenues, and the loss of any of these customers, or the substantial reduction
in the quantity of products that they purchase from us, would significantly reduce our revenues and net income.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently depend
upon a few major OEMs and other customers for a significant portion of our revenues. If our major OEM customers will reduce or
cancel their orders scaling back some of their activities, our revenues and net income would be significantly reduced. Furthermore,
diversions in the capital spending of certain of these customers to new network elements have and could continue to lead to their
reduced demand for our products, which could, in turn, have a material adverse effect on our business and results of operations.
If the financial condition of one or more of our major customers should deteriorate, or if they have difficulty acquiring investment
capital due to any of these or other factors, a substantial decrease in our revenues would likely result. We are dependent on the
electronic equipment industry, and accordingly will be affected by the impact on that industry of current economic conditions.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all of
our existing customers are in the electronic equipment industry, and they manufacture products that are subject to rapid technological
change, obsolescence, and large fluctuations in demand. This industry is further characterized by intense competition and volatility.
The OEMs serving this industry are pressured for increased product performance and lower product prices. OEMs, in turn, make similar
demands on their suppliers, such as us, for increased product performance and lower prices. Such demands may adversely affect our
ability to successfully compete in certain markets or our ability to sustain our gross margins.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our reliance on subcontract manufacturers
to manufacture certain aspects of our products involves risks, including delays in product shipments and reduced control over product
quality.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since we do not own
significant manufacturing facilities, we must rely on, and will continue to rely on, a limited number of subcontract manufacturers
to manufacture our power supply products. Our reliance upon such subcontract manufacturers involves several risks, including reduced
control over manufacturing costs, delivery times, reliability and quality of components, unfavorable currency exchange fluctuations,
and continued inflationary pressures on many of the raw materials used in the manufacturing of our power supply products. If we
were to encounter a shortage of key manufacturing components from limited sources of supply, or experience manufacturing delays
caused by reduced manufacturing capacity, inability of our subcontract manufacturers to procure raw materials, the loss of key
assembly subcontractors, difficulties associated with the transition to our new subcontract manufacturers or other factors, we
could experience lost revenues, increased costs, and delays in, or cancellations or rescheduling of, orders or shipments, any of
which would materially harm our business.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We outsource, and are dependent upon
developer partners for, the development of some of our custom design products.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We made an operational
decision to outsource some of our custom design products to numerous developer partners. This business structure will remain in
place until the custom design volume justifies expanding our in house capabilities. Incomplete product designs that do not fully
comply with the customer specifications and requirements might affect our ability to transition to a volume production stage of
the custom designed product where the revenue goals are dependent on the high volume of custom product production. Furthermore,
we rely on the design partners&rsquo; ability to provide high quality prototypes of the designed product for our customer approval
as a critical stage to approve production.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We face intense industry competition,
price erosion and product obsolescence, which, in turn, could reduce our profitability.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate in an industry
that is generally characterized by intense competition. We believe that the principal bases of competition in our markets are breadth
of product line, quality of products, stability, reliability and reputation of the provider, along with cost. Quantity discounts,
price erosion, and rapid product obsolescence due to technological improvements are therefore common in our industry as competitors
strive to retain or expand market share. Product obsolescence can lead to increases in unsaleable inventory that may need to be
written off and, therefore, could reduce our profitability. Similarly, price erosion can reduce our profitability by decreasing
our revenues and our gross margins. In fact, we have seen price erosion over the last several years on most of the products we
sell, and we expect additional price erosion in the future.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our future results are dependent on
our ability to establish, maintain and expand our manufacturers&rsquo; representative OEM relationships and our other relationships.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We market and sell
our products through domestic and international OEM relationships and other distribution channels, such as manufacturers&rsquo;
representatives and distributors. Our future results are dependent on our ability to establish, maintain and expand our relationships
with OEMs as well as with manufacturers&rsquo; representatives and distributors to sell our products. If, however, the third parties
with whom we have entered into such OEM and other arrangements should fail to meet their contractual obligations, cease doing,
or reduce the amount of their, business with us or otherwise fail to meet their own performance objectives, customer demand for
our products could be adversely affected, which would have an adverse effect on our revenues.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We may not be able to procure necessary
key components for our products, or we may purchase too much inventory or the wrong inventory.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The power supply industry,
and the electronics industry as a whole, can be subject to business cycles. During periods of growth and high demand for our products,
we may not have adequate supplies of inventory on hand to satisfy our customers' needs. Furthermore, during these periods of growth,
our suppliers may also experience high demand and, therefore, may not have adequate levels of the components and other materials
that we require to build products so that we can meet our customers' needs. Our inability to secure sufficient components to build
products for our customers could negatively impact our sales and operating results. We may choose to mitigate this risk by increasing
the levels of inventory for certain key components. Increased inventory levels can increase the potential risk for excess and obsolescence
should our forecasts fail to materialize or if there are negative factors impacting our customers&rsquo; end markets. If we purchase
too much inventory or the wrong inventory, we may have to record additional inventory reserves or write-off the inventory, which
could have a material adverse effect on our gross margins and on our results of operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Although we depend on sales of our legacy
products for a meaningful portion of our revenues, these products are mature and their sales will decline.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A relatively large
portion of our sales have historically been attributable to our legacy products. We expect that these products may continue to
account for a meaningful percentage of our revenues for the foreseeable future. However, these sales are declining. Although we
are unable to predict future prices for our legacy products, we expect that prices for these products will continue to be subject
to significant downward pressure in certain markets for the reasons described above. Accordingly, our ability to maintain or increase
revenues will be dependent on our ability to expand our customer base, to increase unit sales volumes of these products and to
successfully, develop, introduce and sell new products such as custom design and value-added products. We cannot assure you that
we will be able to expand our customer base, increase unit sales volumes of existing products or develop, introduce and/or sell
new products.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Failure of our information technology
infrastructure to operate effectively could adversely affect our business.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend heavily on
information technology infrastructure to achieve our business objectives. If a problem occurs that impairs this infrastructure,
the resulting disruption could impede our ability to record or process orders, manufacture and ship in a timely manner, or otherwise
carry on business in the normal course. Any such events could cause us to lose customers or revenue and could require us to incur
significant expense to remediate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are subject to certain governmental
regulatory restrictions relating to our international sales.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of our products
are subject to International Traffic in Arms Regulation (&ldquo;ITAR&rdquo;), which are interpreted, enforced and administered
by the U.S. Department of State. ITAR regulation controls not only the export, import and trade of certain products specifically
designed, modified, configured or adapted for military systems, but also the export of related technical data and defense services
as well as foreign production. Any delays in obtaining the required export, import or trade licenses for products subject to ITAR
regulation and rules could have a material adverse effect on our business, financial condition, and/or operating results. In addition,
changes in United States export and import laws that require us to obtain additional export and import licenses or delays in obtaining
export or import licenses currently being sought could cause significant shipment delays and, if such delays are too great, could
result in the cancellation of orders. Any future restrictions or charges imposed by the United States or any other country on our
international sales or foreign subsidiary could have a materially adverse effect on our business, financial condition, and/or operating
results. In addition, from time to time, we have entered into contracts with the Israeli Ministry of Defense which were governed
by the U.S. Foreign Military Financing program (&ldquo;FMF&rdquo;). Any such future sales would be subject to these regulations.
Failure to comply with ITAR or FMF rules could have a material adverse effect on our financial condition, and/or operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;&nbsp;</P>



<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We depend on international operations
for a substantial majority of our components and products.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We purchase a substantial
majority of our components from foreign manufacturers and have a substantial majority of our commercial products assembled, packaged,
and tested by subcontractors located outside the United States. These activities are subject to the uncertainties associated with
international business operations, including trade barriers and other restrictions, changes in trade policies, governmental regulations,
currency exchange fluctuations, reduced protection for intellectual property, war and other military activities, terrorism, changes
in social, political, or economic conditions, and other disruptions or delays in production or shipments, any of which could have
a materially adverse effect on our business, financial condition, and/or operating results.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We depend on international sales for a portion of our revenues.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales to customers
outside of North America accounted for 56.9% and 29.9% of net revenues for the years ended December 31, 2019 and 2018, and we expect
that international sales will continue to represent a material portion of our total revenues. International sales are subject to
the risks of international business operations as described above, as well as generally longer payment cycles, greater difficulty
collecting accounts receivable, and currency restrictions. In addition, Gresham, our wholly-owned subsidiary in the United Kingdom,
supports our European and other international customers, distributors, and sales representatives, and therefore is also subject
to local regulation. International sales are also subject to the export laws and regulations of the United States and other countries.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our sales and profitability may be affected
by changes in economic, business and industry conditions</B>.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the economic climate
in the United States or abroad deteriorates, customers or potential customers could reduce or delay their technology and entertainment
investments. Reduced or delayed technology and entertainment investments could decrease our sales and profitability. In this environment,
our customers may experience financial difficulty, cease operations and fail to budget or reduce budgets for the purchase of our
products and professional services. This may lead to longer sales cycles, delays in purchase decisions, payment and collection,
and can also result in downward price pressures, causing our sales and profitability to decline. In addition, general economic
uncertainty and general declines in capital spending in the information technology sector make it difficult to predict changes
in the purchasing requirements of our customers and the markets we serve. There are many other factors which could affect our business,
including:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The introduction and market acceptance of new technologies, products and services;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">New competitors and new forms of competition;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The size and timing of customer orders (for retail distributed physical product);&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The size and timing of capital expenditures by our customers;&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Adverse changes in the credit quality of our customers and suppliers;&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Changes in the pricing policies of, or the introduction of, new products and services by us or
our competitors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Changes in the terms of our contracts with our customers or suppliers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The availability of products from our suppliers; and&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Variations in product costs and the mix of products sold.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These
trends and factors could adversely affect our business, profitability and financial condition and diminish our ability to achieve
our strategic objectives.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The sale of our products is dependent
upon our ability to satisfy the proprietary requirements of our customers.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend upon a relatively
narrow range of products for the majority of our revenue. Our success in marketing our products is dependent upon their continued
acceptance by our customers. In some cases, our customers require that our products meet their own proprietary requirements. If
we are unable to satisfy such requirements, or forecast and adapt to changes in such requirements, our business could be materially
harmed.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The sale of our products is dependent
on our ability to respond to rapid technological change, including evolving industry-wide standards, and may be adversely affected
by the development, and acceptance by our customers, of new technologies which may compete with, or reduce the demand for, our
products.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rapid technological
change, including evolving industry standards, could render our products obsolete. To the extent our customers adopt such new technology
in place of our products, the sales of our products may be adversely affected. Such competition may also increase pricing pressure
for our products and adversely affect the revenues from such products.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our limited ability to protect our proprietary
information and technology may adversely affect our ability to compete, and our products could infringe upon the intellectual property
rights of others, resulting in claims against us, the results of which could be costly.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our products
consist entirely or partly of proprietary technology owned by us. Although we seek to protect our technology through a combination
of copyrights, trade secret laws and contractual obligations, these protections may not be sufficient to prevent the wrongful appropriation
of our intellectual property, nor will they prevent our competitors from independently developing technologies that are substantially
equivalent or superior to our proprietary technology. In addition, the laws of some foreign countries do not protect our proprietary
rights to the same extent as the laws of the United States. In order to defend our proprietary rights in the technology utilized
in our products from third party infringement, we may be required to institute legal proceedings, which would be costly and would
divert our resources from the development of our business. If we are unable to successfully assert and defend our proprietary rights
in the technology utilized in our products, our future results could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we attempt
to avoid infringing known proprietary rights of third parties in our product development efforts, we may become subject to legal
proceedings and claims for alleged infringement from time to time in the ordinary course of business. Any claims relating to the
infringement of third-party proprietary rights, even if not meritorious, could result in costly litigation, divert management&rsquo;s
attention and resources, require us to reengineer or cease sales of our products or require us to enter into royalty or license
agreements which are not advantageous to us. In addition, parties making claims may be able to obtain an injunction, which could
prevent us from selling our products in the United States or abroad.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we are unable to satisfy our customers&rsquo;
specific product quality, certification or network requirements, our business could be disrupted and our financial condition could
be harmed.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers demand
that our products meet stringent quality, performance and reliability standards. We have, from time to time, experienced problems
in satisfying such standards. Defects or failures have occurred in the past, and may in the future occur, relating to our product
quality, performance and reliability. From time to time, our customers also require us to implement specific changes to our products
to allow these products to operate within their specific network configurations. If we are unable to remedy these failures or defects
or if we cannot effect such required product modifications, we could experience lost revenues, increased costs, including inventory
write-offs, warranty expense and costs associated with customer support, delays in, or cancellations or rescheduling of, orders
or shipments and product returns or discounts, any of which would harm our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we ship products that contain defects,
the market acceptance of our products and our reputation will be harmed and our customers could seek to recover their damages from
us.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are complex,
and despite extensive testing, may contain defects or undetected errors or failures that may become apparent only after our products
have been shipped to our customers and installed in their network or after product features or new versions are released. Any such
defect, error or failure could result in failure of market acceptance of our products or damage to our reputation or relations
with our customers, resulting in substantial costs for us and our customers as well as the cancellation of orders, warranty costs
and product returns. In addition, any defects, errors, misuse of our products or other potential problems within or out of our
control that may arise from the use of our products could result in financial or other damages to our customers. Our customers
could seek to have us pay for these losses. Although we maintain product liability insurance, it may not be adequate.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>Some
of our business is subject to U.S. government procurement laws and regulations</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">We
must comply with certain laws and regulations relating to the formation, administration and performance of federal government contracts.
These laws and regulations affect how we conduct business with our federal government contracts, including the business that we
do as a subcontractor. In complying with these laws and regulations, we may incur additional costs, and non-compliance may lead
to the assessment of fines and penalties, including contractual damages, or the loss of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>



<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Microphase</U></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase has a history of losses and
our future profitability on a quarterly or annual basis is uncertain, which could have a harmful effect on our business and the
value of our company.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the past three
fiscal years Microphase has incurred losses from operations. These losses are attributable to lower volumes of its products sold
to major defense contractors partially as a result of the overall reduction in defense spending and sequestration by the U.S. Congress.
Since the financial crisis of 2008, Microphase has been significantly short of capital needed to acquire parts for production of
its products to complete orders for such products. At times, Microphase has not had the cash available to make advance payments
for the purchase of parts, and then, as a consequence, Microphase would not receive the parts from its vendors required to finish
a customer order. This would then delay the delivery of products to customers, and would also delay recognition of the resulting
revenues and the receipt of cash from the customer. Sometimes after experiencing a delay in delivery of an order from Microphase,
the customer would not place its next order with Microphase, resulting in a loss of business.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase&rsquo;s
future profitability depends upon many factors, including several that are beyond its control. These factors include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in the demand for ITS products and services;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">loss of key customers or contracts;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the introduction of competitive products;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the failure to gain market acceptance of ITS new and existing products; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the failure to successfully and cost effectively develop, introduce and market new products, services
and product enhancements in a timely manner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Microphase
is incurring significant legal, accounting, and other expenses related to being a reporting company without there being a trading
market for any of its securities. As a result of these expenditures, Microphase will have to generate and sustain increased revenue
to achieve and maintain future profitability.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A large percentage of Microphase&rsquo;s
current revenue is derived from prime defense contractors to the U.S. government and its allies, and the loss of these relationships,
a reduction in U.S. government funding or a change in U.S. government spending priorities or bidding processes could have an adverse
impact on its business, financial condition, results of operations and cash flows.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase is highly
dependent on sales to major defense contractors of the U.S. military and its allies, including Lockheed Martin, Raytheon, BAE Systems
and SAAB. The percentages of its revenue that were derived from sales to these named major defense contractors and directly to
the U.S. Government were 51.5% in fiscal 2019 and 55.6% in fiscal 2018. Therefore, any significant disruption or deterioration
of Microphase&rsquo;s relationship with any such major defense contractors or the U.S. Government could materially reduce its revenue.&nbsp;
During the year ended December 31, 2019 there were three customers that accounted for more than 10% of sales:&nbsp; BAE Systems,
Raytheon Company and Lockheed Martin.&nbsp; During the year ended December 31, 2018 there were four customers that accounted for
more than 10% of sales: BAE Systems, Raytheon Company, Saab and Lockheed Martin. Microphase&rsquo;s competitors continuously engage
in efforts to expand their business relationships with the same major defense contractors and the U.S. Government and will continue
these efforts in the future, and the U.S. Government may choose to use other contractors. Microphase expects that a majority of
the business that it seeks will be awarded through competitive bidding. Microphase operates in highly competitive markets and its
competitors have more extensive or more specialized engineering, manufacturing and marketing capabilities than Microphase does
in many areas, and Microphase may not be able to continue to win competitively awarded contracts or to obtain task orders under
multi-award contracts. Further, the competitive bidding process involves significant cost and managerial time to prepare bids and
proposals for contracts that may not be awarded to Microphase, as well as the risk that Microphase may fail to accurately estimate
the resources and costs required to fulfill any contract awarded to us. Following any contract award, Microphase may experience
significant expense or delay, contract modification or contract rescission as a result of its competitors protesting or challenging
contracts awarded to it in competitive bidding. Major defense contractors to whom Microphase supplies components for systems must
compete with other major defense contractors (to which Microphase may not supply components) for military orders from the U.S.
Government.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Microphase
competes with other policy needs, which may be viewed as more necessary, for limited resources and an ever-changing amount of available
funding in the budget and appropriation process. Budget and appropriations decisions made by the U.S. Government are outside of
Microphase control and have long-term consequences for its business. U.S. Government spending priorities and levels remain uncertain
and difficult to predict and are affected by numerous factors, including until recently sequestration (automatic, across-the-board
U.S. Government budgetary spending cuts), and the purchase of our products could be superseded by alternate arrangements. While
the US defense budget was recently increased, there can be no assurance that this increase will be maintained for the foreseeable
future, particularly in light of the recent federal expenditures the federal government has made with a view to ameliorating the
economic damage suffered as a result of COVID-19. A change in U.S. Government spending priorities or an increase in non-procurement
spending at the expense of our programs, or a reduction in total U.S. Government spending, could have material adverse consequences
on Microphase&rsquo;s future business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s U.S. government contracts
may be terminated by the federal government at any time prior to their completion, which could lead to unexpected loss of sales
and reduction in Microphase&rsquo;s backlog.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the terms of Microphase&rsquo;s U.S.
government contracts, the U.S. government may unilaterally:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 38.7pt"></TD><TD STYLE="width: 31.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>terminate or modify existing contracts;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 38.7pt"></TD><TD STYLE="width: 31.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reduce the value of existing contracts through partial termination; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 38.7pt"></TD><TD STYLE="width: 31.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>delay the payment of Microphase&rsquo;s invoices by government payment offices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The federal government
can terminate or modify any of its contracts with Microphase or its prime contractors either for the federal government&rsquo;s
convenience, or if Microphase or its prime contractors default, by failing to perform under the terms of the applicable contract.
A termination arising out of Microphase&rsquo;s default could expose it to liability and have a material adverse effect on its
ability to compete for future federal government contracts and subcontracts. If the federal government or its prime contractors
terminate and/or materially modify any of Microphase&rsquo;s contracts or if any applicable options are not exercised, Microphase&rsquo;s
failure to replace sales generated from such contracts would result in lower sales and would adversely affect its earnings, which
could have a material adverse effect on Microphase&rsquo;s business, results of operations and financial condition. Microphase&rsquo;s
backlog as of December 31, 2019 was approximately $6.4 million. Microphase&rsquo;s backlog could be adversely affected if contracts
are modified or terminated.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s products with military
applications are subject to export regulations, and compliance with these regulations may be costly.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase is required
to obtain export licenses before filling foreign orders for many of its products that have military or other governmental applications.
United States Export Administration regulations control technology exports like its products for reasons of national security and
compliance with foreign policy, to guarantee domestic reserves of products in short supply and, under certain circumstances, for
the security of a destination country. Thus, any foreign sales of its products requiring export licenses must comply with these
general policies. Compliance with these regulations is costly, and these regulations are subject to change, and any such change
may require Microphase to improve its technologies, incur expenses or both in order to comply with such regulations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase depends on U.S. government
contracts issued to major defense contractors, which often are only partially funded, subject to immediate termination, and heavily
regulated and audited. The termination or failure to fund, or negative audit findings for, one or more of these contracts could
have an adverse impact on Microphase&rsquo;s business.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over its lifetime,
a U.S. Government program awarded to a major defense contractor may be implemented by the award of many different individual contracts
and subcontracts. The funding of U.S. Government programs is subject to Congressional appropriations. Although multi-year contracts
may be authorized and appropriated in connection with major procurements, Congress generally appropriates funds on a fiscal year
basis. Procurement funds are typically made available for obligations over the course of one to three years. Consequently, programs
often receive only partial funding initially, and additional funds are designated only as Congress authorizes further appropriations.
The termination of funding for a U.S. Government program with respect to major defense contractors for which Microphase is a subcontractor
would result in a loss of anticipated future revenue attributable to that program, which could have an adverse impact on its operations.
In addition, the termination of, or failure to commit additional funds to, a program for which Microphase is a subcontractor could
result in lost revenue and increase its overall costs of doing business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, U.S. Government
contracts are subject to oversight audits by U.S. Government representatives. Such audits could result in adjustments to Microphase&rsquo;s
contract costs. Any costs found to be improperly allocated to a specific contract will not be reimbursed, and such costs already
reimbursed must be refunded. Microphase has recorded contract revenues based on costs Microphase expect to realize upon final audit.
However, Microphase does not know the outcome of any future audits and adjustments, and Microphase may be required to materially
reduce its revenues or profits upon completion and final negotiation of audits. Negative audit findings could also result in termination
of a contract, forfeiture of profits, suspension of payments, fines and suspension or debarment from U.S. Government contracting
or subcontracting for a period of time.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, U.S. Government
contracts generally contain provisions permitting termination, in whole or in part, without prior notice at the U.S. Government&rsquo;s
convenience upon the payment only for work done and commitments made at the time of termination. Microphase can give no assurance
that one or more of the U.S. Government contracts with a major defense contractor under which Microphase provides component products
will not be terminated under these circumstances. Also, Microphase can give no assurance that it will be able to procure new contracts
to offset the revenue or backlog lost as a result of any termination of its U.S. Government contracts. Because a significant portion
of Microphase&rsquo;s revenue is dependent on its performance and payment under its U.S. Government contracts, the loss of one
or more large contracts could have a material adverse impact on its business, financial condition, results of operations and cash
flows.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase&rsquo;s
government business also is subject to specific procurement regulations and other requirements. These requirements, though customary
in U.S. Government contracts, increase its performance and compliance costs. In addition, these costs might increase in the future,
thereby reducing Microphase&rsquo;s margins, which could have an adverse effect on its business, financial condition, results of
operations and cash flows. Failure to comply with these regulations and requirements could lead to fines, penalties, repayments,
or compensatory or treble damages, or suspension or debarment from U.S. Government contracting or subcontracting for a period of
time. Among the causes for debarment are violations of various laws, including those related to procurement integrity, export control,
U.S. Government security regulations, employment practices, protection of the environment, accuracy of records, proper recording
of costs and foreign corruption. The termination of a U.S. Government contract or relationship as a result of any of these acts
would have an adverse impact on Microphase&rsquo;s operations and could have an adverse effect on its standing and eligibility
for future U.S. Government contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s business could be
negatively impacted by cybersecurity threats and other security threats and disruptions.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a U.S. Government
defense contractor, Microphase faces certain security threats, including threats to its information technology infrastructure,
attempts to gain access to its proprietary or classified information, threats to physical security, and domestic terrorism events.
Microphase&rsquo;s information technology networks and related systems are critical to the operation of its business and essential
to its ability to successfully perform day-to-day operations. Microphase is also involved with information technology systems for
certain customers and other third parties, which generally face similar security threats. Cybersecurity threats in particular,
are persistent, evolve quickly and include, but are not limited to, computer viruses, attempts to access information, denial of
service and other electronic security breaches. Microphase believes that it has implemented appropriate measures and controls and
has invested in skilled information technology resources to appropriately identify threats and mitigate potential risks, but there
can be no assurance that such actions will be sufficient to prevent disruptions to mission critical systems, the unauthorized release
of confidential information or corruption of data. A security breach or other significant disruption involving these types of information
and information technology networks and related systems could:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">disrupt the proper functioning of these networks and systems and therefore its operations and/or
those of certain of its customers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">result in the unauthorized access to, and destruction, loss, theft, misappropriation or release
of, proprietary, confidential, sensitive or otherwise valuable information of Microphase or its customers, including trade secrets,
which others could use to compete against Microphase or for disruptive, destructive or otherwise harmful purposes and outcomes;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">compromise national security and other sensitive government functions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">require significant management attention and resources to remedy the damages that result;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">subject Microphase to claims for breach of contract, damages, credits, penalties or termination;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">damage Microphase&rsquo;s reputation with its customers (particularly agencies of the U.S. Government)
and the public generally.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any
or all of the foregoing could have a negative impact on its business, financial condition, results of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase enters into fixed-price contracts
that could subject it to losses in the event of cost overruns or a significant increase in inflation.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase has a number
of fixed-price contracts which allow it to benefit from cost savings but subject it to the risk of potential cost overruns, particularly
for firm fixed-price contracts, because Microphase assumes the entire cost burden. If its initial estimates are incorrect, Microphase
can lose money on these contracts. U.S. Government contracts can expose Microphase to potentially large losses because the U.S.
Government can hold Microphase responsible for completing a project or, in certain circumstances, paying the entire cost of its
replacement by another provider regardless of the size or foreseeability of any cost overruns that occur over the life of the contract.
Because many of these contracts involve new technologies and applications, unforeseen events such as technological difficulties,
fluctuations in the price of raw materials, problems with its suppliers and cost overruns, can result in the contractual price
becoming less favorable or even unprofitable to Microphase. The U.S. and other countries also may experience a significant increase
in inflation. A significant increase in inflation rates could have a significant adverse impact on the profitability of these contracts.
Furthermore, if Microphase does not meet contract deadlines or specifications, Microphase may need to renegotiate contracts on
less favorable terms, be forced to pay penalties or liquidated damages or suffer major losses if the customer exercises its right
to terminate. In addition, some of its contracts have provisions relating to cost controls and audit rights, and if Microphase
fails to meet the terms specified in those contracts Microphase may not realize their full benefits. Microphase&rsquo;s results
of operations are dependent on its ability to maximize its earnings from its contracts. Cost overruns could have an adverse impact
on its financial results.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Enertec</U></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Potential political, economic and military
instability in Israel could adversely affect our operations.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Enertec&rsquo;s operating
facilities are located in Israel. Accordingly, political, economic and military conditions in Israel directly affect Enertec&rsquo;s
operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel
and its Arab neighbors. A state of hostility, varying in degree and intensity, has led to security and economic problems for Israel.
Since October 2000, there has been an increase in hostilities between Israel and the Palestinian Arabs, which has adversely affected
the peace process and has negatively influenced Israel&rsquo;s relationship with its Arab citizens and several Arab countries,
including the Israel-Gaza conflict. Such ongoing hostilities may hinder Israel&rsquo;s international trade relations and may limit
the geographic markets where Enertec can sell its products and solutions. Hostilities involving or threatening Israel, or the interruption
or curtailment of trade between Israel and its present trading partners, could materially and adversely affect Enertec&rsquo;s
operations.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Israel-based
companies and companies doing business with Israel have been the subject of an economic boycott by members of the Arab League and
certain other predominantly Muslim countries since Israel&rsquo;s establishment. Although Israel has entered into various agreements
with certain Arab countries and the Palestinian Authority, and various declarations have been signed in connection with efforts
to resolve some of the economic and political problems in the Middle East, we cannot predict whether or in what manner these problems
will be resolved. Wars and acts of terrorism have resulted in significant damage to the Israeli economy, including reducing the
level of foreign and local investment.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, certain
of our officers and employees may be obligated to perform annual reserve duty in the Israel Defense Forces and are subject to being
called up for active military duty at any time. All Israeli male citizens who have served in the army are subject to an obligation
to perform reserve duty until they are between 40 and 49 years old, depending upon the nature of their military service.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Enertec may become subject to claims
for remuneration or royalties for assigned service invention rights by its employees, which could result in litigation and harm
our business.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A significant portion
of the intellectual property covered by Enertec&rsquo;s products has been developed by Enertec&rsquo;s employees in the course
of their employment for Enertec. Under the Israeli Patent Law, 5727-1967, or the Patent Law, and recent decisions by the Israeli
Supreme Court and the Israeli Compensation and Royalties Committee, a body constituted under the Patent Law, Israeli employees
may be entitled to remuneration for intellectual property that they develop for us unless they explicitly waive any such rights.
To the extent that Enertec is unable to enter into agreements with its future employees pursuant to which they agree that any inventions
created in the scope of their employment or engagement are owned exclusively by Enertec (as it has done in the past), Enertec may
face claims demanding remuneration. As a consequence of such claims, Enertec could be required to pay additional remuneration or
royalties to its current and former employees, or be forced to litigate such claims, which could negatively affect its business.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Related to Ownership of Our
Common Stock and this Offering</U></B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;<B>If we
do not continue to satisfy the NYSE American continued listing requirements, our common stock could be delisted from NYSE American.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
listing of our common stock on the NYSE American is contingent on our compliance with the NYSE American&rsquo;s conditions for
continued listing. On July 24, 2020, we were notified by the NYSE American that we were no longer in compliance with the NYSE American
continued listing standards because our reported stockholders' equity was below continued listing standards. The NYSE American
requires that a listed company's stockholders' equity be $6.0 million or more if it has reported losses from continuing operations
and/or net losses in its five most recent fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following
submission of our compliance plan demonstrating how we intend to regain compliance with the continued listing standards, we were
notified on October 8, 2020, that the NYSE American granted us a listing extension on the basis of our plan until January 24, 2022.
We are subject to periodic review by NYSE American staff during the extension period. Failure to make progress consistent with
the plan or to regain compliance with the continued listing standards by the end of the extension period could result in our common
stock being delisted from the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
light of our continued losses, there is no assurance that we will be able to regain compliance with the NYSE American continued
listing standard. If we fail to meet the NYSE American listing requirement, we may be subject to delisting by the NYSE American.
In the event our common stock is no longer listed for trading on the NYSE American, our trading volume and share price may decrease
and we may experience further difficulties in raising capital which could materially affect our operations and financial results.
Further, delisting from the NYSE American could also have other negative effects, including potential loss of confidence by partners,
lenders, suppliers and employees and could also trigger various defaults under our lending agreements and other outstanding agreements.
Finally, delisting could make it harder for us to raise capital and sell securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A substantial number of shares of our
common stock may be sold in this offering, which could cause the price of such shares to decline.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders
are offering up to 5,061,289 shares of our common stock through this prospectus.&nbsp; As of the date of this prospectus, such
shares would represent approximately 21% of our outstanding shares of common stock after giving effect to the sale of the shares
in this offering. This offering could adversely affect the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You may experience future dilution as a result of future
equity offerings.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to raise additional
capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable
for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities
in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at
which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions
may be higher or lower than the price per share paid by investors in this offering.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our common stock price is volatile.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
listed on the NYSE American. In the past, our trading price has fluctuated widely, depending on many factors that may have little
to do with our operations or business prospects. The exercise of outstanding options and warrants may adversely affect our stock
price and a stockholder&rsquo;s percentage of ownership. As of December 31, 2019, we had outstanding options to purchase an aggregate
of 2,763 shares of common stock, with a weighted average exercise price of $731.62 per share, exercisable at prices ranging from
$480 to $1,856 per share and warrants to purchase up to 79,018 shares of common stock, with a weighted average exercise price of
$206.57 per share, at exercise prices ranging from $8 to $2,000 per share.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 2, 2019, pursuant
to the underwriting agreement with A.G.P./Alliance Global Partners entered into on March 29, 2019, as referenced above, we issued
an aggregate of 793,325 shares of common stock, including shares of common stock underlying warrants. The sale of these shares
of our common stock, including those underlying the warrants (assuming exercise thereof), has had a material and adverse effect
on the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have
previously agreed to register shares of common stock, and common stock underlying outstanding warrants and convertible debt in
connection with private placement of our securities that are not being registered in this prospectus. Our shares of common stock
are thinly traded. Therefore, the resale of a large number of shares of common stock and common stock underlying warrants and convertible
debt by the selling stockholders may adversely affect the market price of our common stock.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Volatility in our common stock price may subject us to securities
litigation.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stock markets, in general,
have experienced, and continue to experience, significant price and volume volatility, and the market price of our common stock
may continue to be subject to similar market fluctuations unrelated to our operating performance or prospects. This increased volatility,
coupled with depressed economic conditions, could continue to have a depressing effect on the market price of our common stock.
The following factors, many of which are beyond our control, may influence our stock price:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the status of our growth strategy including the development of new products with any proceeds we
may be able to raise in the future;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">announcements of technological or competitive developments;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">regulatory developments affecting us, our customers or our competitors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">announcements regarding patent or other intellectual property litigation or the issuance of patents
to us or our competitors or updates with respect to the enforceability of patents or other intellectual property rights generally
in the US or internationally;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">actual or anticipated fluctuations in our quarterly operating results;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in financial estimates by securities research analysts;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in the economic performance or market valuations of our competitors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">additions or departures of our executive officers; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">sales or perceived sales of additional shares of our common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>



<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the securities
markets have, from time to time, experienced significant price and volume fluctuations that are not related to the operating performance
of particular companies. Any of these factors could result in large and sudden changes in the volume and trading price of our common
stock and could cause our stockholders to incur substantial losses. In the past, following periods of volatility in the market
price of a company&rsquo;s securities, stockholders have often instituted securities class action litigation against that company.
If we were involved in a class action suit or other securities litigation, it would divert the attention of our senior management,
require us to incur significant expense and, whether or not adversely determined, have a material adverse effect on our business,
financial condition, results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We have a substantial
number of convertible notes, warrants, options and preferred stock outstanding that could affect our price.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to a number of financings, we have a substantial number of shares that are subject to issuance pursuant to outstanding convertible
debt, warrants and options. These conversion prices and exercise prices range from $8 to $2,000 per share of common stock. As of&nbsp;the
date of this prospectus, the number of shares of common stock subject to convertible notes, warrants, options and preferred stock
were 695,004, 4,235,168, 950 and 2,232,&nbsp;respectively. The issuance of common stock pursuant to convertible notes, warrants,
options and preferred stock at conversion or exercise prices less than market prices may have the effect of limiting an increase
in market price of our common stock until all of these underling shares have been issued.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The issuance of shares of our Class
B Common Stock to our management or others could provide such persons with voting control leaving our other stockholders unable
to elect our directors and the holders of our shares of common stock will have little influence over our Management.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although there are
currently no shares of our Class B Common Stock issued and outstanding, our certificate of incorporation authorizes the issuance
of 25,000,000 shares of Class B Common Stock. Each share of Class B Common Stock provides the holder thereof with ten (10) votes
on all matters submitted to a stockholder vote. Our certificate of incorporation does not provide for cumulative voting for the
election of directors. Any person or group who controls or can obtain more than 50% of the votes cast for the election of each
director will control the election of directors and the other stockholders will not be able to elect any directors or exert any
influence over management decisions. As a result of the super-voting rights of our shares of Class B Common Stock, the issuance
of such shares to our management or others could provide such persons with voting control and our other stockholders will not be
able to elect our directors and will have little influence over our management. While we are listed on the NYSE American or any
other national securities exchange it is highly unlikely that we would issue any shares of Class B Common Stock as doing so would
jeopardize our continued listing any such exchange. However, if were to be delisted for some other reason and our shares of Class
A Common Stock trade on an over-the-counter market, then we would face no restriction on issuing shares of Class B Common Stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We have a number
of shares of common stock subject to registration rights.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to a number of financings, we have contractually agreed to register with the SEC shares of common stock, and common stock underlying
outstanding warrants and convertible debt in connection with private placements of our securities. The potential resale at the
same time of a large number of shares of common stock and common stock underlying warrants and convertible debt by the selling
stockholders may adversely affect the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The rights of the holders of common
stock may be impaired by the potential issuance of preferred stock.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of
incorporation gives our board of directors the right to create new series of preferred stock. As a result, the board of directors
may, without stockholder approval, issue preferred stock with voting, dividend, conversion, liquidation or other rights which could
adversely affect the voting power and equity interest of the holders of common stock. Preferred stock, which could be issued with
the right to more than one vote per share, could be utilized as a method of discouraging, delaying or preventing a change of control.
The possible impact on takeover attempts could adversely affect the price of our common stock. Although we have no present intention
to issue any shares of preferred stock or to create a series of preferred stock, we may issue such shares in the future.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The requirements of being a public company
may strain our resources, divert management&rsquo;s attention and affect our ability to attract and retain qualified board members.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a public company
and subject to the reporting requirements of the Exchange Act, and the Sarbanes-Oxley Act of 2002. The Exchange Act requires, among
other things, that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley
Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls for financial
reporting. For example, Section&nbsp;404 of the Sarbanes-Oxley Act requires that our management report on the effectiveness of
our internal controls structure and procedures for financial reporting. Section&nbsp;404 compliance may divert internal resources
and will take a significant amount of time and effort to complete.&nbsp;If we fail to maintain compliance under Section 404, or
if in the future management&nbsp;determines that our internal control over financial reporting are not effective as defined under
Section&nbsp;404, we could be subject to sanctions or investigations by the NYSE American should we in the future be listed on
this market, the SEC, or other regulatory authorities. Furthermore, investor perceptions of our company may suffer, and this could
cause a decline in the market price of our common stock. Any failure of our internal controls could have a material adverse effect
on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently,
it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls
from our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience
in order to meet our ongoing obligations as a public company, particularly if we become fully subject to Section 404 and its auditor
attestation requirements, which will increase costs. Our management team and other personnel will need to devote a substantial
amount of time to new compliance initiatives and to meeting the obligations that are associated with being a public company, which
may divert attention from other business concerns, which could have a material adverse effect on our business, financial condition
and results of operations.</P>





<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we fail to comply with the rules&nbsp;under
the Sarbanes-Oxley Act of 2002 related to accounting controls and procedures, or if we discover material weaknesses and deficiencies
in our internal control and accounting procedures, our stock price could decline significantly and raising capital could be more
difficult.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to comply
with the rules&nbsp;under the Sarbanes-Oxley Act of 2002 related to disclosure controls and procedures, or, if we discover material
weaknesses and other deficiencies in our internal control and accounting procedures, our stock price could decline significantly
and raising capital could be more difficult. Section&nbsp;404 of the Sarbanes-Oxley Act requires annual management assessments
of the effectiveness of our internal control over financial reporting. If material weaknesses or significant deficiencies are discovered
or if we otherwise fail to achieve and maintain the adequacy of our internal control, we may not be able to ensure that we can
conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section&nbsp;404
of the Sarbanes-Oxley Act. Moreover, effective internal controls are necessary for us to produce reliable financial reports and
are important to helping prevent financial fraud. If we cannot provide reliable financial reports or prevent fraud, our business
and operating results could be harmed, investors could lose confidence in our reported financial information, and the trading price
of our common stock could drop significantly.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If securities or industry analysts do
not publish research or reports about our business, or if they change their recommendations regarding our stock adversely, our
stock price and trading volume could decline.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market
for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our
business. Our research coverage by industry and financial analysts is currently limited. Even if our analyst coverage increases,
if one or more of the analysts who cover us downgrade our stock, our stock price would likely decline. If one or more of these
analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets,
which in turn could cause our stock price or trading volume to decline.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The elimination of monetary liability
against our directors, officers and employees under law and the existence of indemnification rights for or obligations to our directors,
officers and employees may result in substantial expenditures by us and may discourage lawsuits against our directors, officers
and employees.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of
incorporation contains a provision permitting us to eliminate the personal liability of our directors to us and our stockholders
for damages for the breach of a fiduciary duty as a director or officer to the extent provided by Delaware law. We may also have
contractual indemnification obligations under any future employment agreements with our officers. The foregoing indemnification
obligations could result in us incurring substantial expenditures to cover the cost of settlement or damage awards against directors
and officers, which we may be unable to recoup. These provisions and the resulting costs may also discourage us from bringing a
lawsuit against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative
litigation by our stockholders against our directors and officers even though such actions, if successful, might otherwise benefit
us and our stockholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We do not anticipate paying dividends
on our common stock and, accordingly, stockholders must rely on stock appreciation for any return on their investment.</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared
or paid cash dividends on our common stock and do not expect to do so in the foreseeable future. The declaration of dividends is
subject to the discretion of our board of directors and will depend on various factors, including our operating results, financial
condition, future prospects and any other factors deemed relevant by our board of directors. You should not rely on an investment
in our company if you require dividend income from your investment in our company. The success of your investment will likely depend
entirely upon any future appreciation of the market price of our common stock, which is uncertain and unpredictable. There is no
guarantee that our common stock will appreciate in value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: -0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: -0.1pt"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: -0.1pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not offering
any shares of our common stock for sale under this prospectus. We will not receive any of the proceeds from the sale of common
stock by the selling stockholders, though we will receive proceeds in the event of any warrant exercise for cash.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If all such warrants
for the purchase of shares covered by this registration statement are exercised for cash, then we will receive gross proceeds of
approximately $6.2 million. Expenses expected to be incurred by us in connection with this registration statement are estimated
at approximately $17,115. The selling stockholders will pay all brokerage commissions and discounts. See &ldquo;Plan of Distribution.&rdquo;
Proceeds to us from exercise of the warrants will be used for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify; text-indent: 0.5in">We are registering
the shares of our common stock in order to permit the selling stockholders to offer the Conversion Shares and Warrant Shares for
resale from time to time. Except for the ownership of the JLA Note and Warrants that we issued pursuant to agreements, the selling
stockholders have not had any material relationship with us or our affiliates within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify; text-indent: 0.5in">The table below
lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by each of
the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each selling stockholder,
based on its ownership of the shares of common stock and Warrants, as of November 23, 2020 and assuming conversion of the JLA Note
and exercise of the Warrants held by the Selling Stockholders on that date, without regard to any limitations on exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify; text-indent: 0.5in">The third column
lists the shares of common stock being offered by this prospectus by the selling stockholders. This prospectus generally covers
the resale of the maximum number of shares of common stock issuable upon the conversion of the related convertible note or exercise
of the related warrants without regard to any limitations on exercising the convertible note and warrants. The fourth column assumes
the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify; text-indent: 0.5in">Beneficial ownership
is determined in accordance with the rules of the SEC. In computing the number of shares beneficially owned by a selling stockholder,
shares issuable upon the conversion of the JLA Note or exercise of the Warrants are included with respect to that selling stockholder.
To our knowledge, subject to community property laws where applicable, each person named in the table has sole voting and investment
power with respect to the shares of common stock set forth opposite such person&rsquo;s name.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify; text-indent: 0.5in">Under the terms
of the JLA Note and Warrants, a selling stockholder may not convert the JLA Note or exercise the warrants to the extent such conversion
or exercise, as applicable, would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially
own a number of shares of common stock which would exceed 4.99% or 9.99% of our then outstanding common stock following such exercise,
excluding for purposes of such determination shares of common stock issuable upon exercise of the Warrants which have not been
exercised. The number of shares in the second column does not reflect this limitation. The selling stockholders may sell all, some
or none of their shares in this offering. See &quot;<I>Plan of Distribution</I>.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify; text-indent: 0.5in">When we refer to
&ldquo;selling stockholders&rdquo; in this prospectus, we mean those persons listed in the table below, as well as their transferees,
pledgees or donees or their successors. The selling stockholders may sell all, a portion or none of their shares at any time. The
information regarding shares beneficially owned after the offering assumes the sale of all shares offered by the selling stockholders.
Except as otherwise indicated, each selling stockholder has sole voting and dispositive power with respect to such shares of common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center">Shares</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center">Shares</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center">Beneficially Owned</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center">Shares to</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center">Beneficially Owned</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Prior to Offering <SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>be Offered <SUP>(2)</SUP></B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>After Offering <SUP>(3)</SUP></B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold">Name of Selling Stockholders</TD><TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Percentage</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Percentage</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">Esousa Holdings, LLC <SUP>(4)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,560,538</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt">Jess Mogul <SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">810,383</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt">James Fallon <SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">134,708</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 10pt">Cavalry Fund I LP <SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">400,000</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 10pt">JLA Realty Associates, LLC <SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">155,660</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 7.5pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(1)</TD><TD STYLE="text-align: justify">Includes shares of common stock issuable upon the exercise of the Warrants notwithstanding such
Warrants may not exercisable until a date that is six months after their issuance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(2)</TD><TD STYLE="text-align: justify">Represents the number of shares of common stock owned by the Selling Stockholder, including shares
that may be issued upon the conversion of the JLA Note or exercise of Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(3)</TD><TD STYLE="text-align: justify">Assumes that the Selling Stockholder has sold all of the Conversion Shares or Warrant Shares, which
may or may not occur.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(4)</TD><TD STYLE="text-align: justify">Consists of: (i) 1,832,597 shares of common stock underlying the MEA Warrant, (ii) 1,536,655 shares
of common stock underlying the Esousa Term Warrants, and (iii) up to 191,286 shares of common stock underlying the EMF Warrants.
Michael Wachs is the Managing Member of Esousa Holdings, LLC, and exercises sole voting and investment power on behalf thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(5)</TD><TD STYLE="text-align: justify">Consists of: (i) up to 45,242 shares of common stock underlying the Mogul Warrant, and (ii) up
to 765,141 shares of common stock underlying the EMF Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(6)</TD><TD STYLE="text-align: justify">Consists of up to 134,708 shares of common stock underlying the EMF Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(7)</TD><TD STYLE="text-align: justify">Consists of 400,000 shares of common stock underlying the Cavalry Warrant. Thomas P. Walsh is the
Manager of Cavalry Fund I LP and exercises sole voting and investment power on behalf of Cavalry Fund I LP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(8)</TD><TD STYLE="text-align: justify">Consists of 155,660 shares of common stock underlying the JLA Note. Steve Caspi is the Manager
of JLA and exercises sole voting and investment power on behalf of JLA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders
of the common stock and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of
its shares of common stock on the NYSE American, LLC or any other stock exchange, market or trading facility on which the shares
are traded or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one
or more of the following methods when selling shares:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the
block as principal to facilitate the transaction;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>privately negotiated transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a
part;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per
share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>a combination of any such methods of sale; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt">&bull;</TD><TD>any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders
may also sell shares under Rule 144 under the Securities Act of 1933, as amended, if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged
by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction
not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction
a markup or markdown in compliance with FINRA IM-2440.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the sale of the common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions
it assumes. The selling stockholders may also sell shares of the common stock short and deliver these securities to close out its
short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders
may also enter into options or other transactions with broker-dealers or other financial institutions or the creation of one or
more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by
this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented
or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders
and any broker-dealers or agents that are involved in selling the shares may be deemed to be &ldquo;underwriters&rdquo; within
the meaning of the Securities Act of 1933, as amended, in connection with such sales. In such event, any commissions received by
such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions
or discounts under Section 2(11) of the Securities Act of 1933, as amended. The selling stockholders have informed us that they
do not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay all the
expenses, estimated to be approximately $ 17,115, in connection with this offering, other than underwriting commissions and discounts
and counsel fees and expenses of the selling stockholders. We have agreed to indemnify the selling stockholders against certain
losses, claims, damages and liabilities, including liabilities under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.9pt">Because
the selling stockholders may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act of 1933, as amended,
they will be subject to the prospectus delivery requirements of the Securities Act of 1933, as amended, including Rule 172 thereunder.
In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act of
1933, as amended may be sold under Rule 144 rather than under this prospectus. There is no underwriter or coordinating broker acting
in connection with the proposed sale of the resale shares by the selling stockholders.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this
prospectus effective until the earlier of (i) the date on which the shares may be resold by the selling stockholders without registration
and without the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to
Rule 144 or (ii) all of the shares have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other
rule of similar effect. The resale shares will be sold only through registered or licensed brokers or dealers if required under
applicable state securities laws. In addition, in certain states, the resale shares may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and
is complied with.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules
and regulations under the Securities Exchange Act of 1934, as amended, any person engaged in the distribution of the resale shares
may not simultaneously engage in market-making activities with respect to the common stock for the applicable restricted period,
as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject
to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, including
Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the selling stockholders or any
other person. We will make copies of this prospectus available to the selling stockholders and have informed them of the need to
deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172
under the Securities Act of 1933, as amended).</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF OUR SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">The
following is a summary of all material characteristics of our capital stock as set forth in our certificate of incorporation and
bylaws. The summary does not purport to be complete and is qualified in its entirety by reference to our certificate of incorporation
and bylaws, and to the provisions of the General Corporation Law of the State of Delaware, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to
issue 500,000,000 shares of Class A Common Stock and 25,000,000 shares of Class B Common Stock, par value $0.001 per share.&nbsp;
As of November 23, 2020, there were 18,487,902 shares of our Class A Common Stock issued and outstanding but no shares of Class
B common stock issued or outstanding. The outstanding shares of our common stock are validly issued, fully paid and nonassessable.
In this prospectus, all references solely to &ldquo;common stock&rdquo; shall refer to the Class A Common Stock except where otherwise
indicated.&nbsp; In this prospectus, all references solely to &ldquo;common stock&rdquo; shall refer to both the Class A Common
Stock and the Class B Common Stock except where otherwise indicated. We are authorized to issue up to 25,000,000 shares of preferred
stock, par value $0.001 per share.&nbsp; Of these shares of preferred stock, 1,000,000 are designated as Series A Convertible Preferred
Stock, 500,000 are designated as Series B Convertible Preferred Stock, and 2,500 are designated as Series C Convertible Redeemable
Preferred Stock. As of November 23, 2020, there were 7,040 shares of Series A Convertible Preferred Stock outstanding, 125,000
shares of Series B Convertible Preferred Stock and no shares of Series C Convertible Redeemable Preferred Stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our shares
of Class A Common Stock are entitled to one vote for each share on all matters submitted to a shareholder vote. Holders of our
shares Class B common stock are entitled to ten votes for each share on all matters submitted to a shareholder vote. Holders of
our common stock do not have cumulative voting rights. Therefore, holders of a majority of the shares of our common stock voting
for the election of directors can elect all of the directors. Holders of our common stock representing a majority of the voting
power of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute
a quorum at any meeting of shareholders. A vote by the holders of a majority of our outstanding shares is required to effectuate
certain fundamental corporate changes such as liquidation, merger or an amendment to our certificate of incorporation.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our common
stock are entitled to share in all dividends that our Board of Directors, in its discretion, declares from legally available funds.
In the event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in
all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over
our common stock. Our common stock has no preemptive, subscription or conversion rights and there are no redemption provisions
applicable to our common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are offering up
to 155,660 shares of common stock issuable upon conversion of the JLA Note and up to 4,905,629 shares of common stock issuable
upon exercise of warrants for an aggregate of up to 5,061,289 shares of our common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
following summary of certain terms and provisions of the JLA Note and the Warrants that are being offered hereby is not complete
and is subject to, and qualified in its entirety by, the provisions of the JLA Note and the Warrants, forms of each of which are
filed as an exhibit to the registration statement of which this prospectus forms a part. Prospective investors should carefully
review the terms and provisions of the form of JLA Note and the Warrants for a complete description of the terms and conditions
of the purchase warrants.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>MEA Warrant</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 10, 2020,
we entered into a Master Exchange Agreement (the &ldquo;Exchange Agreement&rdquo;) with Esousa, which acquired approximately $4.2
million in principal amount, plus accrued, unpaid interest, of certain promissory notes that had been previously issued by the
Company to other entities. Esousa also agreed to purchase additional notes up to an additional principal amount, plus accrued,
unpaid interest, of $3.5 million (the &ldquo;Additional Notes&rdquo;). Pursuant to the Exchange Agreement, we agreed to issue to
Esousa the MEA Warrants, which entitle Esousa to purchase shares of our common stock equal to (i) the amount of the Additional
Notes ultimately purchased by Esousa, multiplied by 0.83, and divided by (ii) the closing bid price of our common stock as of February
7, 2020, or $1.30. This calculation results in the figure 1,832,597 shares of our common stock underlying the MEA Warrant. We also
agreed to file a registration statement to register the sale of the shares of common stock underlying the exercise of the MEA Warrant
by Esousa.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The MEA Warrant is
exercisable, commencing on the date upon which we receive the requisite approvals therefor, for the exercise price of 110% of the
closing bid price of our common stock as of February 7, 2020, or $1.43. The exercise price and number of shares of common stock
issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar
events affecting our common stock and the exercise price. The MEA Warrant will expire on February 10, 2025.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Esousa Term Warrants</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Between February 27,
2020 and July 24, 2020, we issued to Esousa promissory notes (the &ldquo;Notes&rdquo; and each, a &ldquo;Note&rdquo;) in the aggregate
principal face amount of $2,000,000, with an interest rate of 12%. Each such Note is identical but for its date and principal amount.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the issuance of the Notes, we delivered to Esousa warrants (the &ldquo;Esousa Term Warrants&rdquo; and each, an &ldquo;Esousa Term
Warrant&rdquo;) to purchase an aggregate of 1,536,655 shares of our common stock at the respective exercise prices set forth below.
None of the Esousa Term Warrants were deemed &ldquo;issued&rdquo; until we obtained the approval of the NYSE American (the &ldquo;Exchange
Approval&rdquo;), which we received on July 16, 2020. Prior to obtaining Exchange Approval, we were required to obtain our stockholders&rsquo;
approval for such issuance, which was obtained on July 8, 2020. The Esousa Term Warrants carry a term of five years, and provide
Esousa with piggyback registration rights. The exercise price is subject to adjustment for customary stock splits, stock dividends,
combinations or similar events.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The number of shares
of common stock underlying the Esousa Term Warrants was determined, for each Note, by dividing its principal amount by the closing
bid price of the common stock on the date the corresponding Note was delivered. Each Warrant&rsquo;s exercise price was determined
by multiplying the Closing Bid Price of the common stock on the date of the Note by 1.10. Accordingly, the number of Esousa Term
Warrants that were issued upon our receipt of Exchange Approval and their respective exercise price is set forth below:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%"><FONT STYLE="font-size: 10pt"><U>Date of Note</U></FONT></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-size: 10pt"><U>Warrant Shares</U></FONT></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-size: 10pt"><U>Exercise Price</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">February 27, 2020</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">277,778</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1.19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">March 9, 2020</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">144,928</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1.14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">April 6, 2020</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">281,250</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$0.88</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">April 21, 2020</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">90,909</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1.21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">May 27, 2020</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">95,238</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1.16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">July 24, 2020</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">646,552</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1.91</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt"><B>Total:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>1,536,655</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The volume weighted
average exercise price of the Esousa Term Warrants is $1.43. The exercise price and number of shares of common stock issuable upon
exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events
affecting our common stock and the exercise price.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mogul Warrant</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
April 14, 2020, we issued to Jess Mogul (i) a convertible promissory note in the principal amount of $100,000 (the &ldquo;Mogul
Note&rdquo;) and (ii) a warrant (the &ldquo;Mogul Warrant&rdquo;)<FONT STYLE="background-color: white">.</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The principal amount
of the Mogul Note, plus any accrued, unpaid interest at a rate of 10% per annum, will be due and payable on January 12, 2021. The
Mogul Note is convertible into shares of common stock (the &ldquo;Conversion Shares&rdquo;), which amount is determined by dividing
(x) the amount of the Mogul Note to be converted, multiplied by 1.35, by (y) the closing bid price effective on the date of the
notice of conversion, subject to adjustments set forth in the Mogul Note; provided, however, that, subject to the limitations set
forth therein, the number of shares of common stock issued for the initial conversion will not exceed $135,000 divided by a price
per share equal to the closing bid price effective on the date of the notice of conversion for the initial conversion. The total
number of Conversion Shares to be issued pursuant to the Mogul Note will be adjusted on the Trading Day immediately following the
Pricing Period based upon the volume weighted average price (&ldquo;VWAP&rdquo;) of the Company&rsquo;s common stock over the applicable
Pricing Period (the &ldquo;VWAP Shares&rdquo;). VWAP Shares means the number of shares determined by dividing (x) the amount of
principal, plus any accrued and unpaid interest, of the applicable conversion, multiplied by 1.1, by (y) the greater of (I) 75.0%
of the VWAP of the Company&rsquo;s common stock over the applicable Pricing Period, or (II) $0.35 per share. Subject to a floor
price of $0.35, the maximum number of shares issuable upon conversion of the principal amount is 314,286 Conversion Shares. The
Pricing Period will commence after the date on which Mr. Mogul receives the Conversion Shares and ending on the date that is 30
days after receipt thereof, unless earlier terminated by Mr. Mogul. The Pricing Period was terminated on November 13, 2020 and,
as a result, the number of shares issuable pursuant to the Mogul Note is 90,483 Conversion Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mogul Warrant entitles
its holder to purchase, in the aggregate, up to 50% of the number of Conversion Shares issuable pursuant to the Mogul Note at an
exercise price of $1.17 per share for a period of five years subject to certain beneficial ownership limitations, or <FONT STYLE="background-color: white">45,242
shares of common stock</FONT>. The Mogul Warrant is presently exercisable. The exercise price is subject to adjustment for customary
stock splits, stock dividends, combinations or similar events. The Mogul Warrant includes &ldquo;piggyback&rdquo; registration
rights.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Cavalry Warrant</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 28, 2020, we
entered into a Securities Purchase and Exchange Agreement (the &ldquo;Agreement&rdquo;) with Cavalry Fund I LP (&ldquo;Cavalry&rdquo;).
Pursuant to the Agreement, we agreed to exchange a 12% secured promissory note (the &ldquo;Original Note&rdquo;) in the original
principal face amount of approximately $236,000 issued to Cavalry in January 2020 for a new note of like tenor due and payable
on June 30, 2020 (the &ldquo;Exchanged Note&rdquo;) that would become convertible into common stock should we be in default under
the terms of the Exchanged Note. In addition, pursuant to the Agreement, we issued to Cavalry a note due and payable on November
28, 2020 in the principal face amount of $200,000 that, subject to the approval of the NYSE American, becomes convertible into
common stock commencing June 30, 2020 (the &ldquo;Convertible Note&rdquo; and with the Exchanged Note, the &ldquo;Cavalry Notes&rdquo;)
with an original issue discount of 20%. In conjunction with the issuance of the Convertible Note, we also issued to Cavalry a warrant
(the &ldquo;Cavalry Warrant&rdquo;) to purchase an aggregate of 400,000 shares of common stock at an exercise price of $1.07, which
was the closing bid price of the common stock on May 28, 2020. Each of the conversion of the Convertible Note and the exercise
of the Cavalry Warrant is subject to Exchange Approval.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Cavalry Warrant
entitles Cavalry to purchase 400,000 shares of common stock (the &ldquo;Cavalry Shares&rdquo;) at an exercise price of $1.07 per
share for a period of five years, subject to certain beneficial ownership limitations. The Warrant is immediately exercisable once
we obtain Exchange Approval therefor. The exercise price is subject to adjustment for customary stock splits, stock dividends,
combinations or similar events. If within six months from the date of the Cavalry Warrant, there is no effective registration statement
covering the resale of the Cavalry Shares, then the Cavalry Warrant may be exercised via cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>EMF Warrants</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 26, 2020, we
issued to Esousa, Jess Mogul and James Fallon (the &ldquo;Investors&rdquo;) promissory notes (the &ldquo;EMF Notes&rdquo; and each,
an &ldquo;EMF Note&rdquo;) in the aggregate principal face amount of $800,000 (the &ldquo;Loan Amount&rdquo;), with an interest
rate of 12%. The outstanding principal face amount, plus any accrued, unpaid interest, is due by September 26, 2020, or as otherwise
provided in accordance with the terms set forth therein. In connection with the issuance of the EMF Notes, we delivered to the
Investors warrants (the &ldquo;EMF Warrants&rdquo; and each, an &ldquo;EMF Warrant&rdquo;) to purchase an aggregate of 361,991
shares of our common stock at an exercise price of $2.43, subject to adjustments. Exercise of each EMF Warrant is subject to Exchange
Approval.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Each
EMF Warrant entitles its holder to purchase a number of shares of our common stock based on their pro rata portion of the Loan
Amount in EMF Notes. Esousa, Messrs. Mogul and Fallon lent us $300,000, $400,000 and $100,000, respectively, meaning that their
EMF Warrants entitle them to purchase 135,747, 180,996 and 45,249 shares of our common stock, respectively, subject to the amounts
derived should any one of the EMF Investors elect to exercise his EMF Warrant through a cashless exercise, as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Description of the
EMF Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The EMF Warrants entitle
the Investors to purchase an aggregate of 361,991 shares of our common stock at an exercise price of $2.43 per share for a period
of five years, subject to certain beneficial ownership limitations. The EMF Warrants will be immediately exercisable once we obtain
approval thereof by the NYSE American. The exercise price is subject to adjustment for customary stock splits, stock dividends,
combinations or similar events. The EMF Warrants may be exercised via cashless exercise at the option of the Investor. If any Investor
elect to exercise its EMF Warrant on a cashless basis, it will receive a number of shares of our common stock (the &ldquo;<B>Net
Number</B>&rdquo;) derived from the following formula:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net Number = (A x B)/C</P>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A= the total number of shares with respect to which the EMF Warrant is then being exercised.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">B= Black Scholes Value.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C= the closing bid
price of the common stock as of two (2) trading days prior to the time of such exercise, provided, however, that in no event shall
the closing bid price used for the purposes of calculating the Net Number for Esousa, Messrs. Mogul and Fallon be less than $1.50
$0.71, and $0.50, respectively (the &ldquo;Floor Price&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If C is equal to the
Floor Price at the time of all Investors&rsquo; election to exercise their EMF Warrant on a cashless basis, then we would be required
to issue an aggregate of 1,091,135 shares of common stock, the number registered hereby. Should that occur, the number of shares
of common stock issuable to each of Esousa, Messrs. Mogul and Fallon would be 191,286, 765,141 and 134,708, respectively.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, if the Investors
were to elect a cashless exercise of their Warrants based on the closing bid price on Friday, June 26, 2020, or $2.23, then the
Net Number of shares issuable to the Investors would be 343,112.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If there is at any
time an effective registration statement covering the shares of common stock underlying the EMF Warrants, we will have the option
to redeem the EMF Warrants if our common stock trades at $4.83 per share (a 100% premium to the warrant exercise price) for ten
consecutive trading days (the &ldquo;Call Price&rdquo;). If we elect to call the EMF Warrants, we will deliver written notice to
the Investor(s) of our intention to redeem the EMF Warrants within fifteen days. If the Investor(s) does not exercise the EMF Warrant
within the fifteen day period, we will redeem the Warrant for the Call Price. The Investor may exercise its EMF Warrant for cash
or on a cashless basis during the fifteen day period.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>JLA Note</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
August 21, 2020, we issued to JLA Realty Associates, LLC a convertible promissory note in the principal amount of $330,000 (the
&ldquo;JLA Note&rdquo;)<FONT STYLE="background-color: white">.</FONT> The principal amount of the JLA Note, plus any accrued, unpaid
interest at a rate of 12% per annum, shall be due and payable on October 21, 2020. The JLA Note is convertible into shares of common
stock at $2.12 per share of common stock.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent
and registrar for our common stock is Computershare, 8742 Lucent Blvd., Suite 225, Highlands Ranch, CO 80129.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the
securities offered by this prospectus is being passed upon for us by Olshan Frome Wolosky LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;The consolidated
financial statements incorporated in this prospectus by reference from our Annual Report on&nbsp;Form&nbsp;10-K&nbsp;for&nbsp;the
years ended December&nbsp;31, 2019 and 2018, and for each of the years in the period ended December 31,2019, have been so incorporated
in reliance on the report of Marcum, LLP, an independent registered public accounting firm, incorporated herein by reference, given
on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt; background-color: white">We
have filed with the SEC a registration statement on Form S-3 under the Securities Act, with respect to the securities covered by
this prospectus. This prospectus and any prospectus supplement which form a part of the registration statement, does not contain
all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information
with respect to us and the securities covered by this prospectus, please see the registration statement and the exhibits filed
with the registration statement. Any statements made in this prospectus or any prospectus supplement concerning legal documents
are not necessarily complete and you should read the documents that are filed as exhibits to the registration statement or otherwise
filed with the SEC for a more complete understanding of the document or matter. A copy of the registration statement and the exhibits
filed with the registration statement are available at the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
file annual, quarterly and current reports, proxy statements and other information with the SEC. Our filings with the SEC are also
available to the public at no cost from the SEC&rsquo;s website.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DOCUMENTS INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have filed a registration
statement on Form S-3 with the SEC under the Securities Act. This prospectus is part of the registration statement but the registration
statement includes and incorporates by reference additional information and exhibits. The SEC permits us to &ldquo;incorporate
by reference&rdquo; the information contained in documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents rather than by including them in this prospectus. Information that is incorporated by
reference is considered to be part of this prospectus and you should read it with the same care that you read this prospectus.
Information that we file later with the SEC will automatically update and supersede the information that is either contained, or
incorporated by reference, in this prospectus, and will be considered to be a part of this prospectus from the date those documents
are filed. We have filed with the SEC, and incorporate by reference in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Annual Report on Form 10-K for the period ended December 31,
2019</FONT>, <FONT STYLE="font-size: 10pt">filed with the SEC on May 29, 2020, as amended by the Annual Report on Form 10-K/A filed
with the SEC on June 1, 2020;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September
30, 2020;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Current Reports on Form 8-K filed with the SEC on January 2, 2020; January 16, 2020; January 22,
2020; February 6, 2020; February 10, 2020; an amendment filed on February 25, 2020; February 25, 2020; February 25, 2020; February
28, 2020; March 26, 2020; March 27, 2020; an amendment filed on April 9, 2020; April 14, 2020; April 20, 2020; May 1, 2020; May
13, 2020; May 29, 2020; June 29, 2020; July 8, 2020; July 17, 2020; an amendment filed on July 22, 2020; July 24, 2020; August
14, 2020; August 20, 2020; September 17, 2020; September 18, 2020; an amendment filed on September 30, 2020; October 2, 2020; October
13, 2020; October 23, 2020; October 27, 2020; November 11, 2020; and November 20, 2020;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Our Definitive Proxy Statements filed with the SEC on each of May 18, 2020 and November 13, 2020,
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">The description of our common stock contained in our Form 8-A filed with the SEC on January 30,
1997.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also incorporate
by reference all additional documents that we file with the Securities and Exchange Commission under the terms of Sections 13(a),
13(c), 14 or 15(d) of the Exchange Act that are made after the initial filing date of the registration statement of which this
prospectus is a part until the offering of the particular securities covered by a prospectus supplement or term sheet has been
completed. We are not, however, incorporating, in each case, any documents or information that we are deemed to furnish and not
file in accordance with Securities and Exchange Commission rules.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide you,
without charge upon written or oral request, a copy of any and all of the information that has been incorporated by reference in
this prospectus and that has not been delivered with this prospectus. Requests should be directed to DPW Holdings, Inc., 201 Shipyard
Way, Suite E, Newport Beach, California, 92663; Tel.: (949) 444-5464; Attention: Milton C. Ault III, Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt">- 41 -</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 2px solid; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>dpwlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dpwlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  @$! @$!
M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,
M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( #(
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M]/?^#5+]@QM3U_Q'^T%KUHPM]/$GA_POYB\22L!]KN%]E&V('IEI!U6OR5^
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MYXFOYM2OKA_$T!,DLKEFZ]AG '8 "O0?AY\)_B1_P0$_8=^,VN>/-,\+:/\
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L:J"V !D\X KT_.:**\;&?QY>I[&#_@1] HHHKE.H**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>p4_chart.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 p4_chart.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %- L4# 2(  A$! Q$!_\0
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MC,LR:7X9\+^-=5UK4'BB#22+:64Q2-2[X4$C8^+_ .W?^Q#^SWXQ;X=_'O\
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MU3=,+K[_ .O/^O+5?EC_ ,,0?MZ_])HOVK?_ !%C_@F]_P#0BT?\,0?MZ_\
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MN_V<_@MX-_8T\.6OP\\3ZYX:_9VTWX&_M.>)_P!F&Y\6?'#P/XP?2H1\2/\
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ME_["_8I^ 'ASX[_V+\+-4^(OBOX6_P!K:_IG_"T/"OBW3O[.\6^%?L>JW_\
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M+_?^*Y.G_F8Z/^'^@_Z0L?\ !?WGH/\ AW)SV_ZK'[T ?=7_  \/_P"K&?\
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M/^'A_P#U8S_P44_\1F__  VKX5_X>'_\%U_^E=7_ ,ZY?L>?_,31_P /#_\
M@NO_ -*ZO_G7+]CS_P"8F@#[J_X>'_\ 5C/_  44_P#$9O\ \-J/^'A__5C/
M_!13_P 1F_\ PVKX6_X>'_\ !=?_ *5U?_.N7['GZ_\ %$_RS^-)_P /#_\
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M .E=7_SKE^QY_P#,31_P\/\ ^"ZXQG_@W6]N?^"N7['?_P Q/U]* /W^HK\
M?^'A_P#P77_Z5U?K_P ;<OV//T_XHGG]*/\ AX?_ ,%U_P#I75_\ZY?L>?\
MS$T ?O\ 45^ /_#P_P#X+K_]*ZO_ )UR_8\_^8FC_AX?_P %U_\ I75_\ZY?
ML>?_ #$T ?O]17X _P##P_\ X+K_ /2NK_YUR_8\_P#F)H_X>'_\%U_^E=7_
M ,ZY?L>?_,30!^_U%?@#_P /#_\ @NO_ -*ZO_G7+]CS_P"8FC_AX?\ \%U_
M^E=7_P ZY?L>?_,30!^_U%?@#_P\/_X+K_\ 2NK_ .=<OV//_F)H_P"'A_\
MP77_ .E=7IU_XVY_L><?^630!^_U%?@#_P /#_\ @NO_ -*ZO_G7+]CS_P"8
MFC_AX?\ \%U_^E=7_P ZY?L>?_,30!^_U%?S!?$3_@ME_P %8?A1\=?V=?V:
M/'__  0/_L#XV_M8_P#"W?\ AG_P5_P],_9MU3_A/_\ A1'@ZR\?_%;_ (J3
M1?A3J/A+PK_PBOA+4;+5O^*UU[PY_;GG?8/#G]KZG'+9)[__ ,/#_P#@NO\
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MX@_";_D<O^$1\"?VQ_;'_""?V_\ \BII7]G_ -J_V5_IWV'^TKS[_H ****
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MX=_?3K]*_-V]_P""X.KZ=#\+($_:?_8,UG5O#_QO\<_"+]IZ;2_"R67@30?
MFD?M':M\"- _:4TGX@^*/VY/#]O\.?!=A83^"?&/BOX;V&@?M'^([6W\8>&+
MW7O%WP_\ >+M*^(=EY9\-?\ @OKXU\1^&?!_BKQ7^TI_P3'U")/ G[('Q(^(
M?ASPAKVJ:?K5E%\</C==? [XP?"RSN=2_:<UY?"?CGX=V<FD_&R?7==TK7%\
M">&;ZV\">*/ OB."]M?BP'1H5L0Z,:4%)U\=3R_#^]:->O5C.I&=*;LI4/8P
ME5E7]VG%KZO)K%*5%:58SHSQ=.27/@J=.=?WH\L95<4\#1H1FWRU*]7%*,5"
M+DJ="K2QM:5+!5:==_>?QEU;_@KO\6OB+^R=X_\ ^'=_[*/A[_AE_P#: \1_
M'3^R?^'D^OZL/''_  D'[+'[2W[-/_"+&_'["NFGPR;3_AHG_A-1K?V+Q!]H
M/A#_ (1PZ1!_PD']O:)] ?\ #1/_  5WSM'_  3'_91R><?\/0M?[DC.?^'?
MWJ",8QP3G%?'/_!6;]EWX%^)OBEX=\8^)/@1\,_B7XI_;<^ GQ8_X)^0^(-=
M\&6NJ:N/B_XL30/B?^R_K-_XGM=+U+5- \/^&-=\ ^.KF\\66L;7GAV=?#>J
MV]U"-$LQ'X]\/_VCM#^&?PK^%'[8'A3P?^S-^R[\0OB0GPO_ &"_B9^U%\=O
MA<7^"/[-.D?LZ_#CQYJ_Q"TCQQIG@_QM\$[^P\(2_M*:+KO[,OABTU+XP^"O
M!MEXC\/^!I_[8OXM(\'^%/$/+1J*I1=2I%TZM.4(5J5X24*E7&XW#4Z,)RE3
M=?$4Z-++<=BZ-*$I8?#9QAG&56<)4F<E63H^RIN:K1Q%3FEI&-*AA\+7A5?L
MY5)N&+G#/\-A.2$I5:W#]9.,8XARH_I3_P -#_\ !7GO_P $Q?V4N_\ SE"U
M_MGK_P :_NG3Z9]>*3_AHC_@KSG'_#L7]E+/_:4+7_\ Z7[7Y8>/_P#@H=J7
M[3W[/W[4EG^U1XO_ &+?AKX+^!VC_L6_$?5/ FO6TNG^//!OC3XH>*/"WB'P
MA<ZIX@^(GQ<?3O#<MGXK\+I\1/ASXCU?X<>&?%5YX5\8>$M'?PUH'B71+KQ3
MKG)_&3]OCXB^(_VO+[XX?"'QG^Q?I/[1'PC^ '_!17PEX#^"OBKX6>,?%GQQ
MTSP9\#/B;\ O%4/PR^)ESI7Q[\ :K\0_$_QS^%O@CQ?\??@EI_A3_A -$\/^
M%=:;7].T/XM>&+?5O'T_33HSGB?857"C&-+,<17Q$G>AAZ&7Y7/,?:5).4+N
M<X*C5LI1H4*M'$P>(G6IX24X;GQ3M3BTY.%.C&HG&5:O-UI1I05FDIT:%2I3
MG*24IQ=.I[*,74/U\_X:'_X*\_\ 2,7]E+\/^"H>O\'T/_&OZC_AHC_@KQG'
M_#L;]E+/I_P]"U_I_P"*_NOM7YJ^,?\ @J=^T3J_PS^,?C#QQXU_8=T3X1?!
MSQWX U[QI=?&7]G3XA:3X5^,7[-'[1/C+X*#]E?Q'X9O_$/[8R^'O /B#QKX
M.\2?%G7]2UKQA%XW\_5/A]IKQ?##PY$;Z*O#_P!H?_@J%?\ A']K&/\ :0T&
M#]FSQ1\9_ 'PO_;4^!?@;X)Z5H<&F_'[X8^&-"_:,_9<\/Z;J?QT\3>,?C'X
M-T#XD>'M2^&%EXP_;$\-^&K37?V>/"-E\'K/7M77Q]=^"H->^.>F$*-2<Z$)
MQ</:T,;6G"W-7H3PF6_7X8>O0YX>PKU:DZ.&J1KU(?5.>=6NM*-*OIA(/&U(
MTZ+A%3J4Z=&K5DH4*LJL:M6$X56[2H5,-1GB:->"E3JPE24-935/]P/!/[?G
MC?PE\5/AO\$_VX/V8=>_9#\8?&34K;PO\(OB-IWQ0\*_'3]F?XC?$:Z6ZEM?
MA-I'QCT?2? OB+PS\3-7M[62;PIX;^)GPJ\ IXXDCGTWP=?ZYK,2Z;+^E=?S
MX?M(?'CQC^UO_P $"_VJ_P!H/XH:3\-K3XC>%O@)\</BQX1\1?"?QA\)?'_@
MRW^(/[.>N:_X[^!_Q?\ !.J_"+XV_M.?#_P[K,&N> O!'Q!A\-:/\=/BA=>
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M59.3E3ITX.:^M/\ AH?_ (*\GI_P3&_92R.N?^"H6O\ '_G/[OV/2C_AH?\
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M (I7QE_PD_VC^RO^*>\G^TI?T _X:(_X*\=/^'8W[*.3T'_#T/7^1_XK^_\
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ME"<?=G&49*491T:=UH5&<9)M7TE*,E*+C*,H2<)QE&23C*,DXR3U3[GY7_\
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M(Q?V4O\ Q:'K_P#]+^K]4:3//X _GG_"E>PKH_FP_P""7'P?_P""O7_!-?\
M83^!G[%/_#"W[*7QH_X4O_PLW_BY?_#PS7_AS_PDO_"Q?C%\0?BS_P B;_PQ
M9X[_ +'_ +'_ .$[_L#_ )&O5?[0_LK^U?\ 0?MW]FV?W_\ \-#_ /!7K_I&
M+^RE_P"+0]?_ /I?U?JCD>HI,\X]LT[C_K^OZ_R/RO\ ^&A_^"O7_2,7]E+_
M ,6AZ_\ _2_J/^&A_P#@KU_TC%_92_\ %H>O_P#TOZOU1_S_ )_*C_(_K0!^
M5W_#0_\ P5Z_Z1B_LI?^+0]?_P#I?U9.N_MN?\% ?@UI4WCK]H__ ()=W/\
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M /@FM_R5[_@KQ_VE1\5_^L._L*5I_MR_%;]NGX3>.OA7<_ #X@?LK>$?A?\
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M5(14&TW*<8J[E!3^8O\ @H!_R=/_ ,$=?^S_ /Q]_P"N^/VV:_4NORT_;_\
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MJ_ #1?@+\(=1_96^)7[+_B;P)XK_ &0?%^F?%_P#X%^*7@KXK>)O%7Q$\?\
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M7/Z8_P <=OU]OAJU_P""D?[&]QX\\;_#BZ^*6M:!XB^'&K>/=!\9WGC'X/\
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M_AEJ]KJ/Q/\ AAH4/[0/PP\%KXJAT:XC^ /A'6!K7B35?I/]H+_@E1XB\?\
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ML/%,_C7Q#X3U/QY>>/K;Q?$GC%/B->^)[CQZWC$'Q;)XC?Q&S:F?%=$\8_\
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M:%^%&I^#;#2O#6CZ/X T'PC%+IDWU4W_  5@_8!(('Q])XQ_R2SXU D^N?\
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M;33_ !;8^*=$U_Q=I?B'J?\ A[#^P!Q_Q?SI_P!4L^-6?P(^'/%+_P /8?V
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M2W'PRU35+37]=^&WB/P5XA\&6WB&RLO$O]A2]OZ_KL:O5?U_6U_O/UD;X7^
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MVCOVJ_VK?V9/B3XV?6_"_P $OBA\-->^"GQ<^('PG\*^$M+\=>%_'?P^\6^
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MZ_,_K^MC]4,?H./3\O;\.#2@?_7_ ,\\>U?E=_P\I^+V>?\ @D/_ ,%40/\
ML5/V'>?K_P 9U_EBC_AY3\7O^D0__!5#\/"G[#O_ -'6/_U@CWHM_7S_ ,_\
M]=6&W_#?UT_I;'ZHT5^5W_#RGXO?](A_^"J/_A*?L.__ $=='_#RGXO?](A_
M^"J/_A*?L.__ $=?^?Y,9^J-%?*G[+_[9'P;_:RM/'-K\/QXX\(_$/X4ZU9>
M'/C!\$OC#X&U[X7?&GX3ZYJEF=1T>V\:> O$MO!>QZ5X@L$EOO"OC'0;C7?
MOB^SM[NZ\*>)]:@L[N2'ZK]>G'O_ #]* "BBB@ HHHH **** "BBB@ HHHH
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MBRS\6W>CR?#KPO\ LZW>DW7@*3^GWP=I>H:)X7T#1M6\5:_XYU/2]'T^RO\
MQCXILO#FF^(_$]W;VZ17&N:Y8>#_  YX0\+6>JZE*K75[;>'_"WA[2(9Y'CL
M='T^W6.W3XR_9/\ V]?!7[66J2Z1H_P:^.GP@O)?!1\=:*?C'8_"B"'Q+I&G
M^._%/PU\3V^BR_"[XM_%-$O_  ?XS\)WVE:P-9.CV&IP7NEZOX.O_%.BW$^H
M6OW>C*V=O0 ?ADGC],CZTJ=2^$PU!JE4G3G6<L9"--5<4X3GA91J-)M.C7P]
M>,XTYQIJNJT'3CR*,;G6A6Q%>5.%.E%SC45"#F_8+$8?#XBE2BY3;=+ZO.%6
ME&K&5?DKJ56M4DE(?7Y)?\%+_"=I\%->_9U_X*'_  YTNXT[XQ? [X]_L^_!
MGXCW7AU5M+[XO_LO_M*?&_P7\!?'_P *_&YC@D37M"\':U\4=%^-'@Q]324^
M$O%W@87NG76EV.L^(GNOUMKXC_X**?\ )I/CK_L>/@!_ZT1\*>](9XY_P6%U
M35A^PQXK^'^F:G?:):_M!_&O]DW]EGQ=JVEW=U8ZK9_#7]I_]JCX._ GXJII
M=W8SVMW:ZEJ7PU\>>*M&LKRVN[:>QN-1CO8I?,ME1_T>\(^$O"_@'PMX=\#^
M"?#^C^$_!WA'1=-\-^%_#'A_3[72=#\/Z!HUI%8:3H^D:991PVEAIVG64$-K
M:6MO%'%!!$D:* M?FK_P5_\ ^36/AC_V?_\ \$QO_7@_[-U?J43C'^>X'Y<\
MT +1WZ]CQ^7/X?UI-PX]^G^?7M]:CE,F/DV@XYW8Z'L,COCI_A2;LF[-^26N
MZ6WE>[\DWK973:MU?R?9ORZ+[VEWL\LN1R,G^G/_ .KZY&13N_7\/SY_'^E?
MB'^W]JWP:M/VS?@#8?\ !0&7X<0?\$^[[X"_%;R/^&@E\/\ _#)]W^T]%\0/
MA<?"T'QS;QK;_P#"M?\ A(XO W]N7/P9@^)-R^BR:PGBZZ\/6T?BVQTJ>N0^
M+W[>]Y^SC\5_"'P?_9=TGX&Z5\*KC0_AO\1/A?\ "#Q5X:\>I\2OVY[KXY?'
M'QMH_P 3_#7[%/B"3Q_X/\,Z)=?!ZV@_X65J.WP'\7?#.M>&_&WAS4!:?"KX
M4RZ5\1;R*$_;T*-:,:BE7Q%?#QIJ#DZ4Z.)Q>&5/$V?/3Q%18*6,AAZ=*K)Y
M=7PV,Y^25949<I<V(C[.K%86A1Q-2I6I^RIU:56GAY>UPD^::KTJ57%TL)6J
MS]C"ECJ>)P\W&-%5:G[U$@'DC_#C]/TS1GTQGM_C],]?\:_E/^,7_!1X?'3X
M=6ME^TOK/[*VF>#]%^+?[(?Q<O(8XAX'\8?L+_&#PC^W'\#-(?\ 9U_:5UGX
MC?$OQ7I%U\=)? =QXR\;:5XGT#1_@[?KX2\#_$/5(? ;>"AI_C#5OJ+]GG_@
MI3KWCNR\#Z?X6^-?[!.AS^,?VK/VDOV?-9L/ACX.F\<>)O'OQ/M?VD/'/@WX
M9^)O#_PA\.?M4:-XRL8_$?@;3M.^,7Q/\0:=-\6KOQ)IOB+4_']]_P *V^'>
MD:GXS7>C0KUL-A\13BJLL3CL7@J5&A.G5E)X:EA6IJ:G&/[S$5L1AXZQH5(4
M*&)PN)Q-'&4I1VJT_84,37J5(1CA,=2P&)C)OGA6K8>IBH3ITXJ=2O2=",'*
M=&G)T:KJT,3"A6I.$OZ#_P#/X45^!&J_M_\ [9_@KP?XE\6?%WQQ^Q[\'=+^
M GCJ]^"GQ_U7XB_!KQWX07QO\6M*UOQCXD@G_9PTGQK^V)X0A\5^'?&WPCO/
M@7<>$="A\2>,?$MUKGQ3U*_TF;Q5XD\'W?P:O/WDTC4$U33;#486E:*_LK:]
MB,]E<Z;-LN84F7SK"\ O+*4AQYEI=HES;,&BG42HX$J+=/VEXN*E!)QES<U.
MM1CB<+7]U65'&86:Q.%<N6I.C>52E1DN0P]HE4=-IW3JQ<DXN'M*$H4\32C-
M-QG4PM:<:-?V;E"%5J,9S34C3H_S_G\J/\_XTA/IS_\ K[^G]>?2IN:7/RB_
M:@TG1OAK_P %0?\ @F5\7?"FFQ:7XZ_:$G_::_9#^*VK6+FR;QG\)=!_9R^)
MO[4W@JP\3I J_P!O3_#[XE?!<3^!SJ!D7P[;?$/X@_8#&VOW0D_5ZORN_;?_
M .3]?^"+O_9UO[4__KM[]KJOU1I@%? '_!6+_E%E_P %+/\ LP#]LC_UG7XC
M5]_U\ ?\%8O^467_  4L_P"S /VR/_6=?B-0 ?\ !)W_ )19?\$T_P#LP#]C
M?_UG7X<U@?\ !72V35/^"<G[4WAJYFNHM*\;^"=$^'?B2*SN[BQGU'P=\1_'
MGA+P)XUT7[9:/%=VT.O>$O$6M:+=36LT-U':W\S6\T,VR1/Q@_X)[?\ !QY_
MP1C^!W[ O[#WP4^*7[9/_"+_ !-^#_[('[-/PM^(OAG_ (9Y_:KUO_A'?'?P
M_P#@OX*\)^+M"_MGP[\#=7\/ZO\ V1X@TC4-/_M/0M5U/1[_ .S_ &K3-0O;
M*6"YEV?VTO\ @O\ ?\$D/VNOV;_'O[.G[//[6G_"P?C)\3M0^'VE^!_!W_"A
M_P!IGPH=<O\ 2OB;X,\27\ \0^./@UX:\*Z9]GT71=3O?-UC7-/AE^S?9H9)
M+N:W@E/Z_!V_&U_)OY'^:^[FBG]T7)_+Y/\ <[]H_P#:ATC]CFS^ /@CPK^S
M+\9_C+;?%/Q7'\%_AMX1_9\?]GC0K7PSK.A^#-4\2>'_  W?P_'+X[? ?0M'
MTFZ\(^$?$;:'+I%[J.EV$/AF?3]2DTBXO/#]OJ_4?L^_M9^&/VB8-;M?#7PW
M^+'@[QIX \?3?#/XV_#3XDZ1X2\,^.O@3XK7P='XXLH_'EK;^-=7T'Q%HFMZ
M5?\ A^'P]XG^#OB#XI^&_$,GB;2-3T75;[PS#K>OZ/Y'^W)\'_VG?B5XA_94
M\3?LW>#/@3XTN_@;\=[GXR^*],^-_P ;O'_P4MM2M[+X8>/OAWI6@>']4\!?
MLZ_M"S7,VHR?$>_U;4=1U'2M+325\/6=E;6FL'79KK0?SK\??\$__P!K&P^.
M\/[=OBGP;^S+XV^-6KZ]\8_&?Q=TKP-XH^+8USX;?#*?]DO4_@!\/_@?\ ;_
M $_X0+XY^.FH7.I7LOCCQEK.J:[^S3/XT\2Z7H-EI.B^'I/['N_"G*JKI4L7
M6JQ<U2IYA.DI2=)NM1I9=/ 44U%KV&)J5,SIUJ]2#C15"A6=:"C['&74IN4L
M!&CR\]6GAEB4IJ7+.ICLSI8J<HS<8QEA\%3RVO3A"HYU)UJE*%&NZKEA/W_U
MO6+K2)-),6A:EJUK?:BUGJ6H6%UH-M:^&+!=.U"]?Q!KIUO6M(GDT>.>SM]+
M=-!@US6EOM4L9AH[:5%JFI:;SNB_$CP[XN^'.E_%#X?RM\0?#'B/PE:^-/!\
MOAFXT])?&>C:AI::QHC>'Y_$%[H6E"37[26V_LN?6=3TC36:[MY+Z_L;0R7,
M7\E_[$'_  3 UWQC<?";XF>#?V&OV;? &K^$OCI/XF^,?Q-^-ND_$+X/?$KQ
MO\)/&G[.'Q7_ &??%WPI\*_#CQ;_ ,$?_P!B3Q/<Z?H:^-=)\=ZMHOB/P)=^
M$_B]JEE:WOC'XY^-/'.K^(_%FA_9GP!_X)1?M(? GQ;^PMXI\)_!W_@G]X'O
MOV-?AQX4\+:CJ_PGU.3P)XS^,.H2_"_XS> _BAIOCKXD0?L5W?Q%O_#?B_QI
MXU\,?&6PATSQ;X=T1_%U_P",K?QQX%\<Z_8:!\0KSLKTH1H5DL3R5Y?4HT'&
MCS.$J^%Q-?$R<7*<:M*@X8"G"K[D*E3%UK*<*"DLU*BX4ZE.?MG]5Q5>M3;E
M3C'$8;'RPU/ N3C>6)Q=*$\0ITK4L/1C2A75/$>UB?J'XK_;_P!$T3]F[]G/
M]I7PC^SA^T3\6M#_ &EKSX86/A+X?>!)_P!G;2_B1X6O/BY:6TO@^U\;K\5?
MVA/AI\/K9Y-5O;'PYJ4GA7X@^+;:QU:[CN6GD\/176NV_P!&?L[_ !\\*?M'
M?#:U^(OA;2/%/A4IK7BKPCXH\$>.M.L=*\<> /'7@3Q5K?@KQQX&\766D:IK
MVA)K_A;Q1H&JZ1>W/AWQ#XB\.:B;:/5/#NO:UH=[I^J7GYA^+_V)/VI_%W_!
M/;]CK]D_6O"GP0NO''P@\8_ 4_&5_"_[7/[0WPCTF'P?\"_$VGZO;ZW\'_C5
M\,?V>]'^+O\ PF?B.'P]HUQ#9Q:)\*9/#=YJ%_;6_CG5(=*AN]<X_P".'_!)
M34-=^+/@\?!OPK\#S\(=.\,?"K0?"GC3XH>+OB+J/Q\_9&\3>"_B_P"+/BC\
M7/B;\!]1U3PE\2;KXL^-OVJK;Q;)H'QTU/X@?$_X:Z]XPNM*&J?$WQ1\8?#^
MJW/@B&G&A]8Q]-22I_V]BL-E]2,G*"RBE@\#5HXF=1V3<Z]3%THNK'FQ$J<8
M<^&G2E#$9S</:UE2E7G3H8.AB*,Y4HQ>)JRS'&X>O0G&3IR=>.%^HXN+I0I1
MH4:6*;H8RIB\-##_ +O;U&T;NO0DCKUQ^7X#MST4NH/.,@9//8]QZCH3TX]^
M!_.#X _X(=ZCX0^*UM*-"_91TSX%#Q#\7? EUX0T#X<V%MJI_9U?XV6?[5?[
M-/FZ5%\.=/M-8^*7PD^.2R>%)M/U+Q0O@ZQ^%FG:9J&EWVI>*)[ZQ;R;]F7_
M ((D_M ?"+XF_ /4OBMX9_9R^-/@[P%\:=6\9?%_7_&GQ@\,7E[\0?#.H_ G
MXD_!GQ%XI\/?"'X<?\$S_@?IH\??&/4_''ASQU\<-+^+WQJ^,6K?$6X^&'@S
M3O'GQF\>ZE:+XD@>&AAZL5[7$2P\I1]I3C.A*:E"I7JQI1E*,N6C76&C2K8F
MC5LL/5K+#JK65.K6A%:56E[>4(4Z\*2Q'(Z4ZJE4E0HR48JG5H4YVQ&+BX4)
MTU4B\'R8N;IU9QP3_3GXP:78>$/^"SG[#GBOP]:P:;K7QN_8<_;P\ ?$V]M8
MA!+XN\-_!;XE?L<>-/A?:ZVT)C_M.3P3KGQ-^($OAJ74!<MHD/C3Q5#IHM5U
M_4C<?K#^G^?\*_*O]H0%?^"NW_!,1  H7]E'_@J H [*NO?\$_0!V' STQ[8
MK]4Q[_\ Z_?V[_E67]+[VM>VWX_?NKV3:LVDVKWL[*ZV7GKUMLNBT444#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\ ?^
M=IK_ +P _P#P12OW^K\ ?VUOV*?^"IO_  ]-T#_@HO\ \$Z-?_8 _P"3 -*_
M8J\4^%OVU=5_:*_Z.*\5?'36]?T#1/@9X4/_ %)&G:5JNH^-_P#H:[2[\*?\
M@C5Z /NK_@K%_P F ?'S_NEGZ_&KX<]^E?HI7\I_[<'_ !$-?\,S>._^&J?^
M',G_  SS_;WPJ_X6M_PS[_PV]_PN;_A&?^%O^ _,_P"%>_\ "QO^*(_M[[=]
MCV_\))_Q+_LOVG/[[RJ_H(_;2^*OC#X-_LY^.?&?@'S(/&5Q?>!/ _AW68].
MBU=/">J?%+XC^#_A?;>.KK2[A6M-0LO 3>,CXSO;.]7[!<VF@S07S):23.LR
MDXI67-*4HPA&Z7-.;:C'F;48WY9^])QBN7WI)-7J$7.<8*UYRC%7V3E*,5?1
MOXI16SW[)M?4^.3DG!&,=J#]/IUZ^A_V3W_R:_$BT_X*'?'7X;^/=?\ V=/#
M?[+N@^/IO GQY^(7[*W@GX@>/_VP_$DVJ_$+QOX,_97T?]KKPIXK\?:C?_LX
M^(=<\/Z3XK^&D_B+3_'FH6J>+M1\$>/;#2-$\)>'_B#X7UB;7O#/@DG_  7U
MU[Q)X9^('C[X3?L,_$SQMX ^'WP+LOBOK?BC7=1^-_ACP]HWB-?@#X,_:4U7
MPGXP^)V@?LF^/_V>/"FAS_#_ ,6GPWX.U^7XYZEXX\2?%*VTOPUK'PE\(>$O
M$FG?$%.FCA:V)Y?8P]JIX/!9A%<T(R>"S&G4JX&M*G4G&</K%.E-QI32KP?+
M"K1ISG&+S;:E1A.+A.O6JX>"NI1=:A6]A6A[6#E3M3J\T75YO8M4ZLXU)0I3
MD?K_ .+/V'_V:_&?Q?O?CEJO@OQ+IGQ"UQ=.7QO+X)^+OQF^''@OXK)I&G0:
M1ID?QP^%?P\^(/A?X6_'9-.T>VMM'L$^,?@SQPMIHUO!I, CTZ&.V7RSQG_P
M2W_8C\>R_$M_$'PP\8PP_%>]U?4O%&F>&OV@OVC_  -H.EZEXF\5Z5XY\;:E
M\-/#O@CXN>'=!^#%_P#$CQ;HFF:_\5;[X/:=X%N_BMJ,$DOQ&E\3_:KM9_GG
MXP_\%)?VF?A9\7;3X<Z?^P[I'CO0/#_AR'QU\9/&WAGXW?%[5M-^&'@6/1?%
MOCK6=1N=>\,?L9^*?A!!XMT?X>:!H=U!\-_B9\9?A'XS\6>-_%^EZ'X$TWQ3
M\/8)?BW)XMIG_!4_QO\ M+_!&70+;]E/QQ\+/&GQGD\8:/\ #^?QY\3?VE?V
M5O!GB+X-V_P6;XL^)?B?X#_: ^(/[+OP5^)UI\0?#?A.:YTNPTOX6^!+_3H/
M']F+_P +?&U/ -E/\6]-\ZI76'PN)K49)K+85;TJ5:-"5"-3&0P=24+N/LZ%
M7%>TC*M!2I3>$K3LHX=LN,I5)X6,YSY<S5"=.4E*?MHTL+4Q-'GC?6M0P4O:
M4J%5QK1I8FG&#_VE)_8/@[_@FSX,N?VC?VA/CO\ 'OQ!H7QST?XJ^(]#U;X=
M_#*\TKXQ:+X1^'>G:=\&M'^!FHQ^//"7B/\ :(^(GP=^-OC;4/ F@V=E9?%7
M5O@WX1\?Z%_;GCBRLM7?1?%*:5I7H/A'_@FE^Q[X&\5?#3QKX=\#_$6+Q7\(
M?%[>.? ?B#5?VDOVFO$FIZ?K*>$]2\ :9I^LW/B;XPZN_C+P9X9\#:YXA\&^
M"?AQXT/B#X>>!/"_B7Q/H/@WPOH>F>)==M;_ .4O^&W/C'^SM^Q7_P $^_B*
MGP[\(_&:S^,?P8^'F@_$'XD?&#]H7QA\.]2T#XE:I^STWCCP!?:_J.F? WXZ
MZMXUA^+7C;0)? NL^)Y;N+Q%IGB[Q7X7N[/0?',FM7\>G>60?\%2OCK\1O#W
MPG\?:1^RG\.M!TWQ9X9^),WA22\_;&^)UIK?A;]HOX>_L?>)?CEX\^$_Q9^&
M^@_LR:/H>M^#/!6L1>(?A9JFL:OXGU^ZMO&6C6_C6S^&%CK&CZ5_9?5BG]1C
MFL_:PJ0R.G/!8J=*I3C4E3RCW8VBYPGBJM*"IXBI-SKXG_:J&)Q$I5<71=7D
MP^)CF>'RFO5=-/-L!0K8.E6JPJ>SPV/OED,,XI26%IU52J81X9PH0E0H5W[%
MX>E4J1^\O#__  2__8N\+C2O^$>\ ?$?29?#VL^#-=\-W=G^TS^U%'J'A:^^
M'NL?$K6?!:>%-2/QF:_\,:7H+_&#XDZ-:Z%H%SINAR^#O%=[X"N]-N/!%OI_
MA^SJ>&O^"5_[#_A&#X?VVB_#3QV(/AMI]MH^A1ZM^TA^TWXB77M#TOQEJOQ#
M\-^'_BA_PD7QCU4_&OP[X%\=:WJ_BWX:^'_C$?'>C?##Q!J-WJGP^LO#5W,T
MA_/+]C7]L/\ :9TWXX2:K\8?!%EXHT;]H73_ -AR'Q]]C_:9^(?B_P /?!SQ
MQ\8?@=X_U"PUWX-?#OQA\+-+T!?#_CJ\\'^&]1^(OA'PN/@YH7A;6M9N]7T2
MP^(E_!JFJZG9^-_AKX^G_@HM\8+CX&VG[8=R?"-S^QY\5K[XB6O[8?C2Z_9-
M^%/A&[UGQG-^T%X-\8?LD^,/VA)M*\67?Q1^%/@J?1O!V@_#']FSQ-8V?CV]
MT[7H?%?PPUIM2\5SN;='%2HUL33I0IXZ>%QV*]I-T<-CL/1P%.K5KRLG[##T
M,7A5]<:=\/4P_L*<Y5(4HYX?,XX^C1Q%.<Y3QN%I5*$*LVIU\#5Q6.CAHRO>
M3=3$8+%3C@XQJ5(55.K.G&/-5?Z=_ '_ ()\?LO_ +,?C#2_'/P=T3XOZ7K^
MB^"];^'VFIXS_:F_:G^+OA^W\*^(_%]]X^UFQ_X0WXO_ !H\=^#I;^[\7:G?
MZT/$$^@R>(K::\GM[35;>RD:V/VHJJO08SUK\'4_X+'?$W_A&O ?C>?]ECX4
M:9X"^(N@_LZ_&'1_&NJ?M<ZN?#_AC]F?]I?XCCX3>#?B#\2KS0_V7M>3P;\3
M?"_C6_\ #T7C[X7Q'6_!.G:'J6K:OX:^.'BV3P?XHL-.PKG_ (+8?$:T^$_A
MCXAO^QQ8WNO^+?'5A\"['P'X7^*?Q^^(WB+1/VD1K_QPD\1?#;Q5X1^%O[#O
MCKXR6GAK1OAQ\&;;QO9>,?#?P=\6>)M6O?B/X-TJX^&6C>%AK7Q!TRITJL:<
MZDXM0PV+J9?--Q<J&*^L3]M0E!/F@_K^(J4JLTI4O[0K5*$JSQ,Y<_="C>M.
M,(*4YPIUI5Z:4J%5+ 1Q-.V*5J-6K'*J4<7&DINO'+*<<3[)8>*4/Z :^(_^
M"BG_ ":3XZ_['CX ?^M$?"FOGKX#_P#!3#Q=\2K7XH>+/BG^R;\5/@[X ^%4
M_P ,=-\0:?H?A;]HKX[_ +15KXA^+_PA^%'Q9\*>&]7_ &6OA/\ LMZK\4-!
MU7P]!\0->T#XHO?*VF^![OPWHNHVVH>)+#Q-K#>"/>O^"@UY%J'['WC&]@6X
M2&[\8?L]7,27=I=V%TL<_P"T)\*)$6YL;^"VOK*X56 FM+RVM[JWD#0W$,4J
M.@JK1J49<M114E&G*2C.$^3VM.-6G&IR2?LZDJ4H553DN;V<X3>DDA75XIZ.
M<%4@FK.=-V:J1WO!\R][35I6NSQO_@K_ /\ )K'PQ_[/_P#^"8W_ *\'_9NK
M]!?BRWQ,_P"%?>*(O@W>^#-+^*,^ER0>"=5^(NB:QXF\"Z3K<TT$,&J^*O#?
MA[Q+X,UWQ!HVF1R2WUWH>D>+O#-_JRVXL+?7=+DG6]@_/K_@K_\ \FL?#'_L
M_P#_ ."8W_KP?]FZOU$N+=;A=K,RG:ZJRXRI8 ;L'()&,@$$'N".*YZBYH35
MF[QEI&3C)OEDTHR3BXOF4+.ZMK=V;N/FT<>7F4H-<RO'2I3<E)=8N"J)KK=6
MUY6OQC_9]_;=_:'\+Z%XT^*W[;?Q2_9]UCX3:/\ &GX]?LY^%_#_ .S3^R+^
MT;I?QBU_XH?!_P"*&K>#M"G\->!M&_:!_:T\;_%)/&?A'P=X[\::MX*\"?#B
M/6O >GZ%-JM[KVN^'M-UC4[7U+]HC_@IY\%-#^#7Q8U']F_XH^%_%GQBTG]G
M/QS\<OA+J/B3X3?%_P 7_ OQ/>^%OA#+\;]-\):E\0=!A\"_#_4?&6H?#HV/
MC.\^$UE\8=!^*^G>"-3M_&<_AN/0E2YN.?\ %O\ P1V^!WQ)^!7B'X"_%[XQ
M_&?XT:'J7[1OB+]J?PQXD^+/@S]D3QKJGP\^+/C"]\57WBRZT'P1J/[+/_"C
MO%_A[79_''BYY/#OQD^$?Q2L-*EUHSZ -)N-)T"72>DTW_@E/\.?#/PZ^+?P
M:^'?[0GQ[^$_P8^-_P +KOX<_$'X1_##PO\ LE^$_A]/J^J?#_3OA?K/Q0\)
M>&X?V7KFP^&GC/6/!NC:/97WASX:1>$?@X-1L3KMI\*[;6;[4+VZ5Y3PV)A4
M4XXB&"HPP52@H)5,6\OI5*L\6Y-WY<SE7A*<%&+P]*C1A%QQ'UC#=*^ITL=A
MJL*=:MA99G7JXVE5D^2G@8YK4CAZ>%@VY2@\ECAU[.<H5)8JKB*M6I">&C#%
MZ^E_\%8OV/;7PQX?O_&?C7XCZ=XFO(_%6FZWH&D_LK?M9ZIJ&G^)OA[X \*_
M$WQS8#0]+^"^L:O!8V_@'QAHWQ!\+7LZ2V?CCX>3W'C?P1J'BCPMI.KZU9]!
M\8/^"A'P2MK3XC?#CX+_ !5T"3X]V'PX\;:Y\-]3\6?"3XM>)?@=K/COPW\,
M[CXJ6_@D?$338? /PR\=^.-/\'1P>-O$7P8\*?&W2/BM9^!_M/B*ZTW2-*B?
M4XO#;S_@CWHU]XRU+QQ-^WI^W%_:VJV6NV]S NG_ +"@T\7_ (C_ &?= _9F
MU37(H?\ AA\W":E)\+O"^A6D4!NFT:'6; :Q'I(GN;U;G8T__@D!\+M/TH>'
MT_:7_:FG\/6]AKFKZ3HEU=_L[RZ?X?\ C;XF^$=_\#O$/[26BVH_9W2T@^*6
MK_#W6-<MKGPO>6U]\ H?$NM:AXWLO@K:>+YVUDO&Q=6./CA7*BJF70>"J0:C
M5CFU1?OE.$J<Z5+ 8>4.:A)RK8BM"HJ$_9M2KG%AE*E++_;7JQC7D\=SQC5?
MU>&%YJ$8VG25:K/'2=#%2<:=-81?7:5-UDL'+W_X>?\ !0']GS6]=^''PM\9
M>/$T?XR>+O"7A&\U:TLOA]\3H_A=I_CSQ'\,[7XJR?#,?&*7PQ??"+3/B?+X
M)FE\;:5\']3^)+_%*X\#M:>)8O#EYI$R:E-Y/!_P5>_8L^(GBC1/AUX3^*WQ
M,\,WNOZEX<M[KQ+X^_8T_;8\$_#B_P##/BK0_$7B?1[O3OC=XE^%'PU^&'A2
MT\=^$?"_B37?AM\3;SX@3^%]:T[2+K7?#*^)K:*)Z/#'_!+CP%X!U6P\0Z'\
M:_COXR71)_"OCY/AKXZUKX7Z=\,_&O[17P]^$NF_!_P3^T)XR?X?_![PKXWT
M7QY:^%O#_AN+4=(^&WB;P;\)Y]7T:S\8CX4R^-8$UUOBS]FW_@C3\2$^&!^'
M?[2/Q;N_AEX>M?BIX?\ BK?>!/V;+O\ 9 \2Z3\4/%5AX7\1>%/%FO\ Q+^(
MFE_\$N/V3/'.KR_$?1?%&I:5XP?Q59_$;XM77V/3O$"_M!R:Y+?RSF)Y*M7%
M0P]%V@\'6H*L_88>K"I5I+&4V_WDTL-/ZPL/AE"J\3A*6%Q&(G2EBL1A<'%*
M%6GAL*JDW*?U:-'$251UL2\;[+$6K4XPIT8^PG_LLZE9U*4L/6EB\/2=?V&&
MKXO] /@A^V+^Q%X6^'WAOPO\)?%GQ<U;2QXTF\!6&F>(OA5^V!\0OC'JWB"X
M\.6GCO\ X3'QI_PLSP+XD^.GB/PKKWA75-+\46O[0'CU]2\">)]&U?0=3M?B
M+J5KJ^D277H7[?OQ8^.7P2_9OUSXI?L]>(?A3H'C?PUXL^'=G<'XQ_#'Q?\
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M_8S^.>B36FM?&/P1\ _C7X7@MK7XP_LR_M">+_#/PG^/GP5\5B* :KX9\<>
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M\2_"GQ6MM-\7>'?AS\?[#X Z_P#";4-'^*GPNU _M)^+1X9^#GQ&T+XA>/?
M>HZI-=?$JQ\ >*_@9\2/'NC^.?BKX:T.^\(P?;__  P]^WGG)_X+0?M6$@$
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M$"U;XH_#_P <>*MMOKOB#2_^%?66I+K,.B6UUH; _6"BC_/^?\_C10 4444
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M&A*K4S]/_P""P'[*=Q^TG\'_ -E+5WUSPS\7/B]!HD5EI.L>-_V=[I_#&O\
MBS1_$6N^#O#>JZ%X;^.OB#QQXPD\3Z7X:OIK3QE\'/"'Q0^%NBW5SI6C^+_'
MWAS6]6T_3KC]5%8,,@@\ Y!/?OR!Z>]?%7PX_8!_9=^$/BWPMXX^&7AGXE>"
MO$OAE)7O+O0OVC_VD[6T^)5_<ZIK6LSZ_P#'W1?^%MOH?[27BR?6/$6NZG<>
M,/V@=-^)GBF>^U:_N9=9::XD<_:P '3'..G3VP.PK-**BDN9S]MB6Y.+A'V$
MJBEA(*#E.TZ=/GC-\\FTX1E>I"56KK%3]M*T^:@J&&C'FY75EB(0J1Q59N"A
M&-.M+V4H4E&7LYQJN-25.<*=-:_.O]I/_D__ /X)I_\ =Y/_ *I70O\ />OT
M4K\Z_P!I/_D__P#X)I_]WD?^J5T*F;'Z*4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P
M2=_Y19?\$T_^S /V-_\ UG7X<UY;_P %;/\ DD7[(_O_ ,%4?^"6G_K<7P7/
M]*]2_P""3O\ RBR_X)I_]F ?L;_^LZ_#FN9_X*M?#OXC>-?V4+3QC\)_!^I_
M$CQQ^S5^T1^RO^V!8?#+0D\[Q+\2]&_95_:$^'?QO\8^ _"-ME?M_C3Q'X+\
M&^(;+P7I!EMAKOBMM'T1KRQ743>0 'Z2TUE#<'IS]>?\_P J\7_9]_:+^"?[
M4_PN\.?&7X ?$?PO\3OAWXFMA)9:[X9U.WO3I]]%A-2\.^(K!'_M#PSXMT"[
M$NE^)?"FO6VG^(/#NKVUWI6LZ=97]K/ GM//J!^&?\/\^E)I-6:NG;3T::_%
M)_(-_P"OZ[L_/;]I_P#9Q^-^I?M$_ 7]L+]F4_"[Q'\6O@UX%^+'P=USX4?&
MWQAXQ^'7P[^(WPP^,NL?#;Q!KC6_Q*\$^ OBWKGP]\9>%O$'PN\/:KHNJ1_"
MGQS8:Y93ZGX>U.QTU;JTUK3OD[]KC]@G]I[]JCQSX6^(/B"']G"X\1:I\+-#
M\%:?J.K>+?'JZU^PI\1-'^(.K>+I/CY^R-XA_P"%5:O>_$CXH:AHNL:=X,\1
M7^NP?LY/XKLO!/AV[N+W2/#5]X@^'>H?MW3-G3GL1T]2I_/Y<5,(NG]4Y;-8
M"M.K@E.,)K#*M5Q>(KTZ2DK<E7$X[%8F\E.K2KUI3P]2DG*!-1.<*].T5#%4
M*>'Q*48WK0HU,-4HN;=Y7I+"4:7+%QI5L.G0Q-.M2:1_)YK_ /P3>OOAI<?L
MR_!SQ)^P9^R5\4_C7\0_'?[=%IKNMVO@7XY>._V=_#7P1^+'C;QA\4/A=X8^
M)/[2'A3]B;4=/^&L7PPO_'/F_#?X4>+/#W@_P3J7C3PR-3\$^)O"&M:VGB/P
M_P"@_$G_ ((M_M-^(_#GC;P8VM_LY?&7Q;J'PR\;>&H/VL?C#XN\<Z+^T%\8
M]$\4?LO7GP(TG]F?XVZ38?!3XA:5%\ _"'Q%O;#X[:)K]MXV\;_9O$/A+0UL
M/@QIGQ$N-1^+\_\ 4$$P0<],<8_^O^-&P;]^>@(_/'?\*(NM'ZT^=JIC:'U;
M%.*C&G*A&HJT(TJ*2AAYNMSU<14HI/%SK5J5=2P,H8.F1<X8O#XR-G6PN+Q.
M.H2J)5G#$XZ,Z6+G+VKE&K"5%TZ5"E5A)83V%#$4'''T:>+7\\'Q5_X)*_$[
MXF_$3X+ZW9_!;]A'P)X6\$?"IO!OCRX\.V=C=>/O'E[\5/@O\;? /Q\\(_$/
MQIJW[)UWX]^+O@E/B-\2]&^*7A6\N_B-\-=+^(6L6OB+4/BC\,3XMN])\4:?
MY5\//^"/_P"T#X TG5O#.B?L\_\ !//PS\,+GPY^R#?^,_V<_#/Q \6P? []
MJGQC\!? WQ0\(?$SP_\ M!:19?L6:#I]CH'CK6_BE9>/M*\:3^#?BSJ5[XE^
M%7A!_&G@/6+35;FWT+^G;'N>N?\ ZWT]O>F[!Q[9[<\D'K[ 8_&M93G.6*G-
M1E/&5*%6K>,7!RPN,Q&/P\%"3<'2I8S$U:ZIS4XSG[-5G4C1I06<Z7M/J2G*
M<O[/P=? X9JI.+C2Q=)4,75FX3A[7&5Z,?9/&5>?$T8RE]3GAG)R7\Q7@'_@
MD9^U7\*_B]I/Q+T#X:_L7^-M<T3Q#^R!KOA?XC^(?CA\4_"WQ&^'6G_ SXP_
M%SQYX[\*^$9K;]D3QM?W6GP_"'XFZ5^R;X$U?4?&UMKFN_!7P!I,?BRZTG2=
M6E^'VD_TYQ(47!;=T_# ]?Q_SFGA>?PQC\<_E[>E.ISJ3JW=1IMXG$XJZ7*_
M:8JGAJ516C:/)R82ARQY4U-3J2<JM6<FHT(*O]8LU4^I8' 73M#ZOEZJQPR4
M$^6,HQK33Y(PARVC&*BD@K\Z_P!I/_D__P#X)I_]WD?^J5T*OT2=TC1Y)'6.
M.-6D>1V"(B("S.[L0JJJ@EF) "@DG&:_)?3_ (E:;^UY_P %-/A=?_!75M(\
M8_ _]@WX7?'>V^+WQ0T*=-5\-:E^TE\<CX#\&^$/@]X6\164DVE:SJW@#X?>
M'?B-XC^*5O8S7'_"-ZAX@\ Z5>21:C<W=K;P;GZU4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'P!_P2=_Y19?\ !-/_ +, _8W_ /6=?AS7W_7P!_P2=_Y19?\ !-/_ +,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[1(_4.BBBLS0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /@#_@D[_P HLO\ @FG_ -F ?L;_ /K.
MOPYKRW_@K:,_"']D?_M*A_P2U'Y_MQ?!?!_ UZE_P2=_Y19?\$T_^S /V-__
M %G7X<U1_P""H7P=^)GQ=_90O-0^"N@R>,OC!\ ?C)^SQ^UO\-?A]"\$4_Q.
M\4?LI_&[P+\=8_AA93W+QVUMJ_Q$T[P1J/A#P_=73K9VWB+6-)GOLV4=PI/Z
M_/\ S#^OZ_K\SW/]H'X,>)_B%K/P;^)/P[U/P[IWQ1^!'CR^\8^%(/%T5V/#
M'BG1/%'A36_ /C[P-K^H:99ZCJ^AVGB'PIXBN[S2/$&FZ;JLNA>,="\+:Q?:
M%XCT>QU/P[JWS'X8_P""8O@WP_\  WX_? >^_:3_ &EO%FC?'^W^.MGJ7C/Q
M$G[-T/CCX>V/[2_C2[\?_&^S^'3>&?V<?#G@V*+QUXHU"_OYY?&_@SQQ<Z&E
MTEEX8GT.QL-)MK#ZS_9F_:?^"G[7GPIT/XQ? SQE9^*O#.J"6RU?3I$DTSQ?
MX#\56$CVOB'P!\1_"&H+!X@\!_$#PGJD-UH_B;PCXEL=/UG2-2M)X9[;9Y<L
MGT%CDGU[<_GUQ^G]<R[^SJ4KOV=:%:E55W[U*O"G"K3OTISC2BG&/+;FK6M[
M>MSNG.K2<73J3I\E?!XJ*@U%?6LOGB9X/%M1BN;$X=XS$1A6FY5/92C1DY4J
M5&$/ST^!'_!.KP-\ ?A]XP^&GAKXZ_M"Z[X;\1^%O'7ACP[_ &KJOPA\)WGP
MEG^)ND>&[3X@>)_A&WP>^#7POL_!OB3Q-XB\-_\ "P7=;*_T?0/'6O\ B?4O
M"6C>']+UJ?1D^3[/]FW]DKX+Z=\3_P#@EA9_'7]K#1?B)^W7X<\8_$K4/$GA
M[]G;PZ9[C1U\$^$/AY\;/%VD_%KP%^QA#^R/X6U7QC::%I]W\5KOQS:2ZY:^
M/OBG!J]DGAOQ)\2/ 8N/VZ('7) SDX_^MSSW-?E5^TW=?M#^$_V^OV>OC5\.
MOV+OC]^T3\,OAE^S9^T/X \2>)_A%XY_8_T#=XN^-?CCX!:QX>TG3]'^/_[4
MWP.\07/]A:=\&-=N/$^H-I46F0#7_"L.@WGB">7Q##X>M.-?%M8N<_98O!8O
M"XJK%)3G2P.!QF99;A7-4Y*G3KYOAL#1DU&+GSP@Y*4:4H5AJ=.$5RN-%X&K
M6S3 74.2AF=1QI2Q%*G--.O.E7Q*3A:<?:59Q<8SK*?,>(_^"6'P[^*?A_XB
M^ _BE^U;^VE\4?'DWPD@^!V@_&#QM:? ;0M;^%7PC\9WWAG6?%'A'X-Z3X5_
M96\#_LUWE]XVC\!Z5I7CSQI/\*_'GQ.MM,6'2;WQAHCKH2VGS)KW_!+KXR^,
M/CG^TSJ?QE^*][X8^$W[4F@>*O@CXD^*/PBM?V=/B1^T5\0/AAX]\-MX1MO#
MGBZ75O\ @EI;?$WX26^GR&UU>ZUR[_:Z^*7P4\'S#5;/PE\+_AOX9U+PUI?@
MCB?C)X4_X*+^,/CMJ/B*V_9&_P""CVG_  N\0_'OX5?%/Q!X?^#G[?/[/>@:
M;9_#&Y_96U_P!\6_A1X475/^"@GPON]#=_BQJOAG4UT70?#_ (2\+Z7X@T#Q
M'\1/AUXATCQ0=$\4:]Y=\(O@]_P54TWXB_LQ3?$'X'_\%%K[0$TK]G _M$ZM
MK?[=WP+O?#L'C/P[!\;/A_\ &_6+G0- _;X-Q>>$];\#>)OA)K T3P5X9NK?
M6M>\(W7Q#;PR?C);/X@US*$J[E"LV_:QJ1P$*,JD4E_;$'B\RQ-.I&<'A\/#
M$>U6*QL9?[1C:KK8K#8CV]XY*'L,//$X>K"C6PN&H9O1="$HXYU\!BI8/ 8'
M#KE3J8VCAXQQ%/"RE2CA,'*,<%B*=53:_2CQG_P26^"/QK\&>/\ PUXE_:5_
M:.\9^ _C'XCM?%7Q-T9=0_9IU?PA\1/%&F_ +0_V9]<UC7-$D_9SO?#$VI:G
MH7@SPSXP:73M.LW\ _%;PO:^(_A6/AW;/JVAW\?A+PI\ ?@IXE_:?_9)UK]L
M[]IR;XL_M$ZQX"UO7/%_Q%^&?POT6Z\ ZY\:/ VH?"GX<S?"/XAZ7^R+X0_9
MWU:X\2Z3\'3X0T'3_&-M\48SX[\+VGAK4+5_&/B#^R->_-3]GK]B[_@JG\'?
M&/[&&@^'M7_:#^'_ ,*/ACX*\&:-XIT76?BRO[0.C:#\0M#\:^/8?C5??%6#
MQ)_P4W^&OA_6?A+\:?#][X.U'X=/%\$/VNO%7PST"'?X,^'7P"\7V&H:%KVA
MIGP;_:[\,Z)^T)X5^,_P@^/WAGXR?M4_LH_!/X >!_BE\2/V@/AO^T+I_BG]
MM;P=\4OC-X@\6^._ACH&D?&#QQX\^&_PF@NOB'I?QX\":78>!_ /PY^&7P[\
M"^*)M5\%?!G5-$L?#>O]SPM'%>WIXG%4*E*NY9=5H3TJ8JAA_8T<+'#\T/JU
M/"U*668>E1Y>2M%T,)2AA:M&NIQFO!4:56ES0<LJ5''Y;B5S5<'1Q^-QE+#X
MZMRPA/%U:M'"XW%8O%2A3<*U-5:E3%QEA53K?M)KO[!7AC6/@C^SK\*+/X\?
M'OP[XS_97N=+OO@Q^T?X?N/@O;_&W0+S3O!NO?#>>;4=/U#X+:E\"/$<&M?#
MGQ+K/@O6]*USX(WVB7NGSV^KQZ7;^+=/T_Q%:^+>,_\ @CU^RSXOT_1M/BU[
MXQ>$X_#WP@\$_"K2;OPMXNT"+4;/6/AM\4-3^+O@/XWQ76N^#M>/_"]/#/B[
MQ/X[?3?&[(UE%I_Q$\:6O]@%]2M)]/\ U1M8YDMX4GG^T3+&BR2E GFNJ@,_
ME@X3<P8[1P,X''%6<9S\W.>Q/'7W/KR..U<\ISE5E4E4=2<L3+%.;]Y2Q#A4
MI.K:4;+W:E1I*,8QJ2=6,85DIPG#)T*-"G04\-"CAZ6'I4Z4G3=+#TL1#&4\
M/>G)MTZ>)A&K"#<XQDWRMQE.$OQG^,__  0[_9-^,'Q%^,WQ-T_Q+XY^$?B7
MXZ^")_ _CC4_AW\,?V-==\7V]KJ7P_TWX5:[JG@_XQ?&[]E+XP_'SP)=Z]\-
M]*A\&ZEHGA'XL:1X(73;K5+RP\)6.NZMJ6KW/M/QMT>?0/VXO^"7NC7.L:CX
MAGTO3/VNM.GUW6(M*AU?69K'X&^'[>75M4BT+3-%T./4=1=#=WJ:/HVD:4ES
M+(NGZ986@AM(OTMEDB@BDGFDCABBC>6::5ECBCCC4O))*[D(D:*"SN[ *H)+
M 9-?D+X ^)VD_MQ_\%)O"OQ,^">MIXP_9A_8&^%OQQ^'/B+XK:*MO??#WXE?
MM;?'/4OAMI5[X+^'?BB*9[7QFGP&^&'@GQ/:?$#7O#SWOAK2O%GQ1LO"#7U[
MXCT37;3P\>TJNE3HRJ5)4::2ITY3E.--0YE",%-OEC&,W%1C:*BHQMRPA:O9
MQ<X5+>]!5;-:?QE355M)\LI3]E3<IR3DY)R;YI3O^OU%%%2:!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR'_@I!C_ -:QS^&<5ZE_P]B_X)9?])+/V /_ !,G]G7_ .>-1_P]A_X)8_\
M22S]@#_Q,G]G7O\ ]U&]N@I_TN__  /5?)H73^OZ_3NF>6_\.8OV"O\ H"_M
M6_\ BR'_ (*0_P#T65'_  YA_8*_Z O[5O\ XLA_X*0__195ZE_P]B_X)9?]
M)+/V /\ Q,C]G7_YXU'_  ]B_P""67_22S]@#_Q,C]G7_P">-0,\WM?^",G_
M  3P!GA\0_"?XI?$K2+N VU[X2^-G[7G[9/QY\ ZA"TD4CKJ7P[^-'Q_\>>!
M=2,BQFVD>^\/7$DEA<W^FNS:?J-_;7/Z-^ _ 7@?X6^#?#7PZ^&G@[PO\/O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\@?V3O"7_  5-_9?_ &6/V:?V:/\ AE_]@#QQ_P ,[_L__!OX
M%_\ ":_\/$?VBO#/_"8?\*D^'7ASP!_PE/\ PCG_  ZT\0?\(_\ \)!_PC_]
MK?V)_;VM_P!E?:_L']KZE]G^V3?._P#P43\9?MVZSX7_ &.+#XZ_LX_LE?#C
MX<R?\%1_^"8CZGXJ^$O[:OQB^-7C6TO8OVU_@V^E6]AX \8_L"? +0M1M;V^
M$-MJ%Y<?$K2YM,M'DO;:QU>:);";^@:ORN_X*V?\DB_9'_[2H_\ !+3_ -;B
M^"] 'ZHU\!_%O]ASQ7\2?CGXI^//A+]N7]KSX#ZYXJ\ :#\,[KPG\(=(_8TO
M/"&F^$= GU#4(++2)/C)^R#\7?&MK?76MZUK>O3ZS+XSN-9MM0U:Y@TF^TW2
M+;3-+L/OS_/^?\_TH_R/ZUG.G"4H3<5*=/VG)=)I>UHU*%2\97A+GHU:M*2D
MFG3J5(/W9N[4I1C.$;<M10C-.,9*2I5J6(I_$I6<*]"C5BU9JI3A)7<4C\:?
M%G_!%KX0?$*V\3Z#\2/VHOVMOB+X \8>+_BOXS\4?#;QE/\ LL:OX9\07OQ:
M\-^&?#.J6&M:N?V6(?B!K&E^'[7P?X=OM"&I^-[S4M1U.QEE\<ZEXRMM2U6S
MOOG'X:_LN?\ !.CX'>*_CQ\$Y/VJ/BSX;TS1?V0/C_\ #'XF>!=4_9]_9G_9
M<^!MU\&]3UZSG^.WQ,^'OB?X%_L)_LX_"GX@>./AQK%UI.A_$/7?A=XK\70>
M ]3?2])^)'AV#6KE(KK^B,Y[ $X]<9]!T/O7XV_M3_#KX^?M4^/OBKX0E_9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=G92:_XMU_5;^'3;*PTJSDMM+L+*RMP#Z+HH_P _Y_S_ $HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
0* "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
